SlideShare a Scribd company logo
1 of 88
Draft document for comment
1 SUPPLEMENTARY GUIDELINES ON
2 GOOD MANUFACTURING PRACTICES FOR HEATING,
3 VENTILATION AND AIR-CONDITIONING SYSTEMS FOR
4 NON-STERILE PHARMACEUTICAL DOSAGE FORMS
5 (May 2016)
6 REVISED DRAFT FOR COMMENT
7
8
9
10
11
12 © World Health Organization 2016
13 All rights reserved.
14 This draft is intended for a restricted audience only, i.e. the individuals and organizations having
15 received this draft. The draft may not be reviewed, abstracted, quoted, reproduced, transmitted,
16 distributed, translated or adapted, in part or in whole, in any form or by any means outside these
17 individuals and organizations (including the organizations' concerned staff and member
18 organizations) without the permission of the World Health Organization. The draft should not be
19 displayed on any website.
20 Please send any request for permission to:
21 Dr Sabine Kopp, Group Lead, Medicines Quality Assurance, Technologies, Standards and Norms,
22 Department of Essential Medicines and Health Products, World Health Organization, CH-1211
23 Geneva 27, Switzerland. Fax: (41-22) 791 4730; email: kopps@who.int
24
25 The designations employed and the presentation of the material in this draft do not imply the
26 expression of any opinion whatsoever on the part of the World Health Organization concerning the
27 legal status of any country, territory, city or area or of its authorities, or concerning the delimitation
28 of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which
29 there may not yet befull agreement.
30 The mention of specific companies or of certain manufacturers’ products does not imply that they
31 are endorsed or recommended by the World Health Organization in preference to others of a similar
32 nature that are not mentioned. Errors and omissions excepted, the names of proprietary productsare
33 distinguished by initial capital letters.
34 All reasonable precautions have been taken by the World Health Organization to verify the
35 information contained in this draft. However, theprinted material is being distributed without
36 warranty of any kind, either expressed or implied. The responsibility for theinterpretation and use
Should you have any comments on the attached text, please send these to Dr S. Kopp, Group
Lead, Medicines Quality Assurance, Technologies, Standards and Norms (kopps@who.int) with
a copy to Ms MarieGaspard (gaspardm@who.int) by 12 July 2016.
Medicines Quality Assurance working documents will be sent out electronically only and
will also be placed on the Medicines website forcomment under “Current projects”. If you
do not already receive our draft working documents please let us have your email address
(to bonnyw@who.int) and we will add it to our electronic mailing list.
Working document QAS/15.639/Rev.1
page 2
37 of thematerial lies with the reader. In no event shall the World Health Organization be liable for
38 damages arising from its use.
39 This draft does not necessarily represent the decisions or the stated policy of the World Health
40 Organization.
41 SCHEDULE FOR THE PROPOSED ADOPTION PROCESS OF
42 DOCUMENT QAS/15.639
43 SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING
44 PRACTICES FOR HEATING, VENTILATION AND AIR-
45 CONDITIONING SYSTEMS FOR NON-STERILE
46 PHARMACEUTICAL DOSAGE FORMS.
47 PROPOSAL FOR REVISION
Discussion of proposed need for revision in view of the
current trends in engineering and experience gained
during the implementation of this guidance in inspection
during informal consultation on data management,
bioequivalence, GMP and medicines’ inspection
29 June–
1 July 2015
Preparation of draft proposal for revision by Mr D.
Smith, consultant to the Medicines Quality Assurance
group and Prequalification Team (PQT)-Inspections,
based on the feedback received during the meeting and
from PQT-Inspections
July–August 2015
Circulation of revised working document for public
consultation
September 2015
Consolidation of comments received and review of
feedback
10 October 2015
Presentation to the fiftieth meeting of the WHO Expert
Committee on Specifications for Pharmaceutical
Preparations
12–16 October 2015
Consolidation of comments received and review of
feedback
January–March
2016
Discussion at the informal consultation on good
practices for health products manufacture and inspection,
Geneva,
4–6 April 2016
Preparation of revision by Mr D. Smith, based on
comments provided by Mr A. Kupferman and Dr A.J.
Van Zyl, both participants at the above-mentioned
consultation.
May 2016
Working document QAS/15.639/Rev.1
page 4
Circulation of revised working document for public
consultation
May 2016
Working document QAS/15.639/Rev.1
page 3
Consolidation of comments received and review of
feedback
August–September
2016
Presentation to the fifty-first meeting of the WHO Expert
Committee on Specifications for Pharmaceutical
Preparations
17–21 October 2016
Any other follow-up action as required …
48
49
50
51
Working document QAS/15.639/Rev.1
page 4
52 BACKGROUND
53 During the consultation on data management, bioequivalence, GMP and
54 medicines’ inspection held in 2015 the possible revision of the guidance
55 for (WHO Technical Report Series, No. 961, Annex 5, 2011) was
56 discussed with the inspectors. It was suggested that in light of the new
57 developments a draft for revision be prepared. This new proposal for
58 revision was drafted based on the feedback received, the new, current
59 trends in engineering and the experience gained during the implementation
60 of this guidance in inspection.
61 At the same time, the opportunity was used to improve the graphic images
62 and make them more readable in e-version as well as in print.
63 Summary of main changes
64 Below is a list of the main changes that have been made to the WHO Technical
65 Report Series, No. 961, 2011, Annex 5: Supplementary guidelines on good
66 manufacturing practices for heating, ventilation and air-conditioning systems for
67 non-sterile pharmaceutical dosage forms.
68
69 1. The Premises section has been moved towards the beginning of the document
70 due to its important impact on HVAC designs. In addition the text has been
71 expanded and a number of sample layouts have been included.
72
73 2. The HVAC sections have been re-arranged into a more logical sequence.
74
75 3. The Commissioning, Qualification and Validation (C, Q & V) section has
76 been aligned with the proposed revisions to the Supplementary GMP
77 Validation TRS, No. 937, Annex 4 guidelines.
78
79 4. Significant notes were added under the new Supplementary notes on test
80 procedures section.
81
82 5. The Maintenance section has been separated out of the C, Q & V section.
83
84 6. All the diagrams have been revised (mainly to achieve better clarity).
85
86 7. Throughout the document additional notes have been added and text revised
87 to provide better understanding and avoid ambiguity.
88
89
Working document QAS/15.639/Rev.1
page 5
90
91
92
93 1. Introduction
94 2. Scope of document
95 3. Glossary
96 4. Premises
Contents
page
97 5. Design of HVAC systems and components
98 5.1 General
99 5.2 Air distribution
100 5.3 Recirculation system
101 5.4 Full fresh-air systems
102 5.5 Additional system components
103 6. Protection
104 6.1 Products and personnel
105 6.2 Air filtration and air patterns
106 6.3 Unidirectional airflow
107 6.4 Infiltration
108 6.5 Cross-contamination and contamination
109 6.6 Pressure differential concept (high pressure differential,
110 low airflow)
111 6.7 Physical barrier concept
112 6.8 Temperature and relative humidity
113 7. Dust control
114 8. Protection of the environment
115 8.1 General
116 8.2 Dust in exhaust air
117 8.3 Vapour and fume removal
118 9. Commissioning, qualification and validation
119 9.1 General
120 9.2 Commissioning
121 9.3 Qualification
122 9.4 Supplementary notes on test procedures
123 9.4.1 General
124 9.4.2 Airflow measurements
125 9.4.3 Non-variable air particle counts
126 9.4.4 HEPA filter integrity tests
127 10. Maintenance
128 References
129 Further reading
130130
Working document QAS/15.639/Rev.1
page 6
1311
3
1
1321
3
2
1331
3
3
1341
3
4
1351
3
5
1361
3
6
1371
3
7
1381
3
8
1391
3
9
1401
4
0
1411
4
1
1421
4
2
1431
4
3
1441
4
4
1451
4
5
1461
4
6
1471
4
7
148148
149149
150150
151151
152152
153153
154154
155155
156156
157157
158158
159159
160160
161161
162162
163163
164164
165165
166166
167167
168168
169169
170170
171171
172172
173173
174174
Working document QAS/15.639/Rev.1
page 7
1. I
N
T
R
O
D
U
C
T
I
O
N
H
e
a
t
i
n
g
,
v
e
n
t
i
l
a
t
i
o
n
a
n
d
a
i
r
-
c
o
nditioning (HVAC) play an important role in ensuring the manufacture of
quality pharmaceutical products. A well designed HVAC system will also
provide comfortable conditions for operators.
These guidelines mainly focus on recommendations for systems for
manufacturers of non-sterile dosage forms, and include tablets, capsules,
powders, liquids, creams, ointments, etc. The HVAC design principles
contained in the guidelines may be applied to other dosage forms.
HVAC system design influences architectural layouts with regard to items
such as airlock positions, doorways and lobbies. The architectural components
have an effect on room pressure, differential cascades and cross-
contamination control. The prevention of contamination and cross-
contamination is an essential design consideration of the HVAC system. In
view of these critical aspects, the design of the HVAC system should be
considered at the concept design stage of a pharmaceutical manufacturing
plant.
Temperature, relative humidity and ventilation should be appropriate and
should not adversely affect the quality of pharmaceutical products during
their manufacture and storage, or the accurate functioning of equipment.
This document aims to give guidance to pharmaceutical manufacturers
and inspectors of pharmaceutical manufacturing facilities on the design,
installation, qualification and maintenance of the HVAC systems.
These guidelines are intended to complement those provided in Good
manufacturing practices for pharmaceutical products (1) and should be read
in conjunction with the parent guide. The additional standards addressed by
this guide should, therefore, be considered supplementary to the general
requirements set out in the main principles guide (WHO Technical Report
Series, No. 961, Annex 3)
2. SCOPE OF DOCUMENT
These guidelines focus primarily on the design and good manufacturing
practices (GMP) requirements for HVAC systems for facilities for the
manufacture of solid dosage forms. Most of the system design principles
for facilities manufacturing solid dosage forms also apply to facilities
manufacturing other dosage forms (such as liquids, cream, ointments) and
other classes of products including biological products, herbal medicines,
complementary medicines and finishing process steps for APIs.
Non-sterile forms typically include:
Working document QAS/15.639/Rev.1
page 8
1751
7
5
1761
7
6
1771
7
7
1781
7
8
1791
7
9
1801
8
0
1811
8
1
1821
8
2
1831
8
3
1841
8
4
1851
8
5
1861
8
6
1871
8
7
1881
8
8
1891
8
9
1901
9
0
191191
192192
193193
194194
195195
196196
197197
198198
199199
200200
201201
202202
203203
204204
205205
206206
207207
208208
209209
210210
211211
212212
213213
214214
Working document QAS/15.639/Rev.1
page 9
 p
r
o
d
u
c
t
s
w
i
t
h
l
o
w
w
a
t
e
r
a
c
t
i
v
i
t
y
(
l
e
s
s
s
u
b
j
e
c
t to microbial contamination), e.g. oral solid dosage forms,
suppositories;
 products with high water activity (more subject to microbial
contamination, depending on the formulation), e.g. liquids,
drops, syrups, ointments and creams.
Additional specific requirements apply for air-handling systems of
pharmaceutical sterile products and hazardous products. Guidelines for
hazardous, sterile and biological product facilities are covered in separate
WHO guidelines (WHO Technical Report Series, No. 957, Annex 3; WHO
Technical Report Series, No. 961, Annex 6; and working document
WHO/BS/2015.2253, intended to replace WHO Technical Report Series,
No. 822, Annex 1, 1992, respectively).
These guidelines are not intended to be prescriptive in specifying requirements
and design parameters. There are many parameters affecting a clean area
condition and it is, therefore, difficult to lay down the specific requirements
for one particular parameter in isolation.
Many pharmaceutical manufacturers have their own engineering design and
qualification standards, and requirements may vary from one manufacturer
to the next. Design parameters and user requirements should, therefore, be
set realistically for each project, with a view to creating a cost-effective
design, yet still complying with all regulatory standards and ensuring that
product quality and safety are not compromised. The three primary aspects
addressed in this guideline are the roles that the HVAC system plays in
product protection, personnel protection and environmental protection
(Figure 1).
Cognizance should be taken of the products to be manufactured when
establishing system design parameters. A facility manufacturing multiple
different products may have more stringent design parameters with respect
to cross-contamination control, compared with a single product facility.
Risk assessment studies should be an integral part of the facility design and
implementation, from the user requirement specification stage right
through to validation, as indicated in the diagram below (Figure 2).
Validation protocols and criteria should be justified by links to a written
risk assessment.
Working document QAS/15.639/Rev.1
page 10
Avoid Effluent
Discharge
Avoid Fume
Discharge
Prevent Contact
with Fumes
Protect from
Product
Contamination
Avoid Dust
Discharge
Prevent Contact
with Dust
Contamination
(Product & Staff)
PROTECTION OF
EXTERNAL
ENVIRONMENT
PERSONNEL
PROTECTION
PRODUCT
PROTECTION
GMP MANUFACTURING
ENVIRONMENT
Correct Temperature
& Humidity
215 Figure 1. The guidelines address the various system criteria according to
216 the sequence set out in this diagram
217217
218218
219219
SYSTEMS
Acceptable Comfort
Conditions
SYSTEM VALIDATION
`
Working document QAS/15.639/Rev.1
page 11
2202
2
0
2212
2
1
Figure 2. GMP compliance sequence diagram
222222
223223
224224
PROJECT
INCEPTION
USER
REQUIREMENT
SPECIFICATION
QUALIFICATION
&
VALIDATION
FACILITY
LAYOUTS
R
RI
IS
SK
K
A
AS
SS
SE
ES
SS
SM
ME
EN
NT
T
S
ST
TU
UD
DI
IE
ES
S
Installations &
Commissioning
V C &
ES
E
ENERGY
EFFICIENCY
STUDIES
Working document QAS/15.639/Rev.1
page 12
2252
2
5
2262
2
6
2272
2
7
2282
2
8
2292
2
9
2302
3
0
2312
3
1
2322
3
2
2332
3
3
2342
3
4
2352
3
5
2362
3
6
2372
3
7
2382
3
8
2392
3
9
2402
4
0
2412
41
242242
243243
244244
245245
246246
247247
248248
249249
250250
251251
252252
253253
254254
255255
256256
257257
258258
259259
260260
261261
262262
263263
264264
265265
266266
267267
268268
269269
Working document QAS/15.639/Rev.1
page 13
3. G
L
O
S
S
A
R
Y
T
h
e
d
e
fi
n
i
t
i
o
n
s
g
i
v
e
n
b
e
l
o
w
a
p
p
l
y
t
o
terms used in these guidelines. Theymay have different meanings in other
contexts.
acceptance criteria. Measurable terms under which a test result
will be considered acceptable.
action limit. The action limit is reached when the acceptance
criteria of a critical parameter have been exceeded. Results outside these
limits will require specified action and investigation.
air changes per hour. The volume of air supplied to a room, in m3/hr,
divided by the room volume, in m3.
air-handling unit. The air-handling unit serves to condition the air
and provide the required air movement within a facility.
airflow protection booth. A booth or chamber, typically for
purposes of carrying out sampling or weighing, in order to provide product
containment and operator protection.
airlock. An enclosed space with two or more doors, which is
interposed between two or more rooms, e.g. of differing classes of
cleanliness, for the purpose of controlling the airflow between those rooms
when they need to be entered. An airlock is designed for and used by
either people or goods (personnel airlock (PAL); material airlock (MAL)).
alert limit. The alert limit is reached when the normal operating
range of a critical parameter has been exceeded, indicating that corrective
measures may need to be taken to prevent the action limit being reached.
as-built. Condition where the installation is complete with all
services connected and functioning but with no production equipment,
materials or personnel present.
at-rest. Condition where the installation is complete with equipment
installed and operating in a manner agreed upon by the customer and
supplier, but with no personnel present.
central air-conditioning unit (see air-handling unit)
change control. A formal system by which qualified representatives
of appropriate disciplines review proposed or actual changes that might
affect a validated status. The intent is to determine the need for action that
Working document QAS/15.639/Rev.1
page 14
2702
7
0
2712
7
1
2722
7
2
2732
7
3
2742
7
4
2752
7
5
2762
7
6
2772
7
7
2782
7
8
2792
7
9
2802
8
0
2812
8
1
2822
8
2
2832
8
3
2842
8
4
2852
8
5
286286
287287
288288
289289
290290
291291
292292
293293
294294
295295
296296
297297
298298
299299
300300
301301
302302
303303
304304
305305
306306
307307
308308
309309
310310
311311
312312
313313
Working document QAS/15.639/Rev.1
page 15
wo
uld
ens
ure
that
the
sys
tem
is
mai
ntai
ned
in a
vali
dat
ed
stat
e.
c
l
e
a
n
a
r
e
a
(
c
l
e
a
n
r
o
o
m
)
.
A
n
area (or room or zone) with defined environmental control of particulate
and microbial contamination, constructed and used in such a way as to
reduce the introduction, generation and retention of contaminants within the
area.
clean-up (see recovery)
closed system. A system where the product or material is not
exposed to the manufacturing environment.
commissioning. Commissioning is the documented process of
verifying that the equipment and systems are installed according to
specifications, placing the equipment into active service and verifying its
proper action. Commissioning takes place at the conclusion of project
construction but prior to validation.
containment. A process or device to contain product, dust or
contaminants in one zone, preventing it from escaping to another zone.
contamination. The undesired introduction of impurities of a
chemical or microbial nature, or of foreign matter, into or on to a starting
material or intermediate, during production, sampling, packaging or
repackaging, storage or transport.
controlled area (classified area). An area within the facility in
which specific environmental parameters, conditions and procedures are
defined, controlled and monitored to prevent degradation or cross-
contamination of the product.
controlled not classified. An area where some environmental
conditions are controlled (such as temperature), but the area has no
cleanroom classification.
critical parameter or component. A processing parameter (such as
temperature or relative humidity) that affects the quality of a product, or a
component that may have a direct impact on the quality of the product.
critical quality attribute. A physical, chemical, biological or
microbiological property or characteristic that should be within an
appropriate limit, range or distribution to ensure the desired product quality.
cross-contamination. Contamination of a starting material,
intermediate product or finished product with another starting material or
Working document QAS/15.639/Rev.1
page 16
314 product during production.
315315
316 cross-over-bench. Cross-over or step-over bench in change room to
317 demarcate the barrier between different garment change procedures.
318318
319 design condition. Design condition relates to the specified range or
320 accuracy of a controlled variable used by the designer as a basis for
321 determining the performance requirements of an engineered system.
322322
323 design qualification. Design qualification is the documented check
324 of planning documents and technical specifications for design conformity
325 with the process, manufacturing, good manufacturing practices and
326 regulatory requirements.
327327
328 differential pressure. The difference in pressure between two
329 points such as the pressure difference between an enclosed space and an
330 independent reference point, or the pressure difference between two
331 enclosed spaces.
332332
333 direct impact system. A system that is expected to have a direct
334 impact on product quality. These systems are designed and commissioned
335 in line with good engineering practice and, in addition, are subject to
336 qualification practices.
337337
338 exfiltration. Exfiltration is the egress of air from a controlled area to
339 an external zone.
340
341 extract air. Air leaving a space, which could be either return air or
342 exhaust air. Return air means that the air is returned to the air-handling unit
343 and exhaust air means that the air is vented to atmosphere.
344
345 facility. The built environment within which the clean area installation
346 and associated controlled environments operate together with their supporting
347 infrastructure.
348348
349 good engineering practice. Established engineering methods and
350 standards that are applied throughout the project life cycle to deliver
351 appropriate, cost-effective solutions.
352352
353 hazardous substance or product. A product or substance that may
354 present a substantial risk of injury to health or to the environment.
355355
356 HEPA filter. High efficiency particulate air filter.
357357
Working document QAS/15.639/Rev.1
page 17
358 HVAC. Heating, ventilation and air-conditioning. Also referred to
359 as Environmental control systems.
360360
361 indirect impact system. This is a system that is not expected to
362 have a direct impact on product quality, but typically will support a direct
363 impact system. These systems are designed and commissioned according to
364 good engineering practice only.
365365
366 infiltration. Infiltration is the ingress of air from an external zone
367 into a controlled area.
368
369 installation qualification. Installation qualification is documented
370 verification that the premises, HVAC system, supporting utilities and
371 equipment have been built and installed in compliance with their approved
372 design specification.
373
374 ISO 14644. The International Standards Organization has developed
375 a set of standards for the classification and testing of cleanrooms. The
376 standard comprises 12 separate parts. Where ISO 14644 is referenced it
377 implies the latest revision.
378378
379 NLT. Not less than.
380380
381 NMT. Not more than.
382382
383 no-impact system. This is a system that will not have any impact,
384 either directly or indirectly, on product quality. These systems are designed
385 and commissioned according to good engineering practice only.
386386
387 non-critical parameter or component. A processing parameter or
388 component within a system where the operation, contact, data control, alarm
389 or failure will have an indirect impact or no impact on the quality of the
390 product.
391391
392 normal operating range. The range that the manufacturer selects as
393 the acceptable values for a parameter during normal operations. This range
394 must be within the operating range.
395395
396 OOS. Out of specification. In relation to HVAC systems this could
397 refer to any of the environmental conditions being OOS,i.e. falling outside of
398 alert or action limits.
399399
400 operating limits. The minimum and/or maximum values that will
401 ensure that product and safety requirements are met.
Working document QAS/15.639/Rev.1
page 18
4024
0
2
4034
0
3
4044
0
4
4054
0
5
4064
0
6
4074
0
7
4084
0
8
4094
0
9
4104
1
0
4114
1
1
4124
1
2
4134
1
3
4144
1
4
4154
1
5
4164
1
6
4174
1
7
4184
18
419419
420420
421421
422422
423423
424424
425425
426426
427427
428428
429429
430430
431431
432432
433433
434434
435435
436436
437437
438438
439439
440440
441441
442442
443443
444444
445445
446446
Working document QAS/15.639/Rev.1
page 19
o
p
e
r
a
t
i
n
g
r
a
n
g
e
.
O
p
e
r
a
t
i
n
g
r
a
n
g
e
i
s
t
h
e
r
a
n
g
e of validated critical parameters within which acceptable products can be
manufactured.
operational condition. This condition relates to carrying out room
classification tests with the normal production process with equipment in
operation and the normal staff present in the specific room.
operational qualification. Operational qualification is the documentary
evidence to verify that the equipment operates in accordance with its design
specifications in its normal operating range and performs as intended throughout
all anticipated operating ranges.
oral solid dosage. Usually refers to an oral solid dosage plant that
manufactures medicinal products such as tablets, capsules and powders to
be taken orally.
pass-through-hatch or pass box. A cabinet with two or more doors
for passing equipment, material or product, whilst maintaining the pressure
cascade and segregation between two controlled zones. A passive pass-
through-hatch (PTH) has no air supply or extract. A dynamic PTH has an
air supply into the chamber.
performance qualification. Performance qualification is the
documented verification that the process and/or the total process related to the
system performs as intended throughout all anticipated operating ranges.
point extraction. Air extraction to remove dust with the extraction
point located as close as possible to the source of the dust.
pressure cascade. A process whereby air flows from one area,
which is maintained at a higher pressure, to another area maintained at a
lower pressure.
qualification. Qualification is the planning, carrying out and
recording of tests on equipment and a system, which forms part of the
validated process, to demonstrate that it will perform as intended.
quality critical process parameter. A process parameter which
could have an impact on the critical quality attribute.
recovery. Room recovery or clean-up tests are performed to determine
whether the installation is capable of returning to a specified cleanliness level
within a finite time, after being exposed briefly to a source of airborne
particulate challenge.
Working document QAS/15.639/Rev.1
page 20
447447
448 relative humidity. The ratio of the actual water vapour pressure of
449 the air to the saturated water vapour pressure of the air at the same
450 temperature expressed as a percentage. More simply put, it is the ratio
451 of the mass of moisture in the air, relative to the mass at 100% moisture
452 saturation, at a given temperature.
453453
454 standard operating procedure. An authorized written procedure,
455 giving instructions for performing operations, not necessarily specific to a
456 given product or material, but of a more general nature (e.g. operation of
457 equipment, maintenance and cleaning, validation, cleaning of premises and
458 environmental control, sampling and inspection). Certain standard operating
459 procedures may be used to supplement product-specific master and batch
460 production documentation.
461461
462 turbulent flow. Turbulent flow, or non-unidirectional airflow, is air
463 distribution that is introduced into the controlled space and then mixes with
464 room air by means of induction.
465465
466 unidirectional airflow. Unidirectional airflow is a rectified airflow
467 over the entire cross-sectional area of a clean zone with a steady velocity
468 and approximately parallel streamlines (see also turbulent flow). (Modern
469 standards no longer refer to laminar flow, but have adopted the term
470 unidirectional airflow.)
471471
472 validation. The documented act of proving that any procedure,
473 process, equipment, material, activity or system actually leads to the
474 expected results.
475475
476 validation master plan. Validation master plan is a high-level
477 document which establishes an umbrella validation plan for the entire
478 project and is used as guidance by the project team for resource and
479 technical planning (also referred to as master qualification plan).
480480
481481
482 4. PREMISES
483483
484 4.1. There is a close relationship between architectural design and
485 HVAC design, as they both have an impact on the functionality of the
486 other. HVAC system design influences architectural layouts with regard to
487 items such as airlock positions, doorways and lobbies. The architectural
488 layouts and building components have an effect on room pressure
489 differential cascades and cross-contamination control. The prevention of
490 contamination and cross-contamination is an essential design consideration
Working document QAS/15.639/Rev.1
page 21
491 of the HVAC system. In view of these critical aspects, the design of the
492 HVAC system should be considered at the concept design stage of a
493 pharmaceutical manufacturing plant, and the design should be closely
494 coordinated with the architectural designers. The above design
495 considerations should also be applicable to facility upgrades or the
496 retrofitting of facilities.
497497
498 4.2. As the efficient operation of the air-handling system and cleanliness
499 levels attained are reliant on the correct building layout and building
500 finishes, the following items should be considered.
501501
502 4.2.1. Adequate airlocks, such as personnel airlocks (PAL) and/or material
503 airlocks (MAL), pass-through hatches (PTH), change rooms and passages
504 should be provided to limit air transfer between different cleanliness zones,
505 and may be provided to limit cross-contamination within the same
506 cleanliness zone. These should have supply and extract air systems as
507 appropriate.
508508
509 4.2.2. Areas such as airlocks, change rooms and passages should be
510 designed so that the required pressure cascades can be achieved.
511511
512 4.2.3. Detailed diagrams depicting pressure cascades, air flow directions
513 and flow routes for personnel and materials should be prepared and
514 maintained.
515515
516 4.2.4. Where possible, personnel and materials should not move from a
517 higher cleanliness zone to a lower cleanliness zone and back to a higher
518 cleanliness zone (if moving from a lower cleanliness zone to a higher
519 cleanliness zone, changing/decontamination procedures should be
520 followed).
521521
522 4.2.5. The final change room should be the same good manufacturing
523 practices (GMP) classification grade (at rest) as the area into which it leads.
524524
525 4.2.6. Door gaps around the door perimeter have a marked impact on the
526 pressure differential across the doorway. The fit of the doors should be
527 agreed upon between the architect and the HVAC designer to ensure that
528 the correct leakages are allowed for. Likewise the maintenance of doors is
529 a critical factor in room pressure control (a poorly fitting door can severely
530 compromise a room pressure differential).
531531
Working document QAS/15.639/Rev.1
page 22
532 4.2.7. Where the opening and closing of airlock doors could lead to cross-
533 contamination, these airlock doors should not be opened simultaneously.
534 An interlocking system and/or a visual and/or audible warning system
535 should be operated to prevent the opening of more than one door at a time.
536536
537 4.2.8. Doors should be carefully designed to avoid un-cleanable recesses.
538 Swing doors should open to the high-pressure side and be provided with
539 self-closers. Exceptions are permitted based on site environmental, fire,
540 health and safety containment requirements. Cognizance should be taken of
541 possible room pressure changes due to fan failure and the impact on ease of
542 opening doors for escape purposes.
543543
544 4.2.9. The choice of building finishes and materials also has an impact on
545 air conditioning performance and air cleanliness. Materials should be
546 selected that will provide a well-sealed building to facilitate room pressure
547 control. Materials and paint finishes should also be non-dust and particle
548 liberating as this impacts on room cleanliness. Finishes should be easy to
549 clean and non-absorbent. To reduce the accumulation of dust and to
550 facilitate cleaning, there should be no uncleanable recesses and a minimum
551 of projecting ledges, shelves, cupboards and equipment.
552552
553 The following diagrams are examples of room and suite layouts with their
554 associated room pressures. These are purely examples and other factors
555 may dictate different room arrangements and room pressures.
556 Room pressure differentials could be lower or higher depending on the
557 specific design and operations. The purpose of a pressure differential is to
558 enhance the separation between areas with different levels of cleanliness
559 and also to provide containment to prevent cross-contamination. Where
560 there is no difference in cleanliness level, and no potential for cross
561 contamination, a zero pressure differential can be applied.
562562
Working document QAS/15.639/Rev.1
page 23
5635
6
3
5645
6
4
5655
6
5
5665
6
6
5675
6
7
5685
6
8
5695
69
Working document QAS/15.639/Rev.1
page 24
35 Pa
Staff
Airlock
BIN BIN
25 Pa
COB
BIN
Floor
Scale
35 Pa
Change
Room Pallet
BIN BIN
Flow 25 Pa
BIN
BIN
Airf low Protection
Plenum
Wash Bay
25 Pa
DispensaryPre-Staging Room 15 Pa
DispensaryPost-Staging
Perf orated Worktop
Table Scale
Weigh Booth
Fig
ure
3.
Ex
am
ple
of a
wei
gh
boo
th
lay
out
N
o
t
e
:
S
i
milar air handling and product protection principles apply to
sampling suites.
Return
Air
Shaft
Staff
Flow
Material
Flow
Material
Flow
Room
Working document QAS/15.639/Rev.1
page 25
COB
570 Figure 4. Example of a dispensary suite
Production Passage
Dispensary
Post-Staging
Room
Staff Flow
Wash
Bay
Optional
location
MAL
Change
Room
MAL
Change
Room
Weigh
Booth 1
Airf low
Protection
Plenum
Weigh
Booth 2
Airf low
Protection
Plenum
Broken
Bulk
Store
MAL
Wash
Bay
Optional
location
MAL
Wash
Bay
Optional
location
Dispensary Pre-Staging Room Material Flow
5715
7
1
5725
7
2
Notes:
Staff Flow
Material Flow
MAL
W/h Staff
573 1. Two alternative locations are indicated for the wash bays.
574 2. The broken bulk store is optional. Alternatively partially used
575 containers can be returned to the warehouse.
576 3. The inclusion of MALs at entrance and exit to weigh booths depend on
577 containment risks and the pressure cascade design.
Return
Air
Shaft
Return
Air
Shaft
Material
Flow
Material
Flow
S
ta
ff
Flow
S
ta
ff
Flow
S
ta
ff
Flow
S
ta
ff
Flow
Material
Flow
Material
Flow
Material
Flow
S
ta
ff
Flow
S
ta
ff
Flow
S
ta
ff
Flow
S
ta
ff
Flow
Warehouse
Area
Working document QAS/15.639/Rev.1
page 26
578578
579579
Working document QAS/15.639/Rev.1
page 27
15 Pa
Female
Toilets
-10 Pa
Lobby
0 Pa
COB
15 Pa
-10 Pa
Male
Toilets
COB
Production
Passage
Female
Change
Room
Male
Change
Room
Un-classified Zone
5805
8
0
5815
8
1
5825
8
2
Figure 5. Change rooms and washing area layouts
30 Pa
Working document QAS/15.639/Rev.1
page 28
583 Figure 6. Example of a compression cubicle with change room and MAL,
584 for higher risk materials.
585585
586 Note: The inclusion of the PAL and MAL is dependent on product risk,
587 range of products handled in adjacent cubicles, pressure cascade and open
588 vs closed manufacturing processes.
589589
590590
Change
Room
25 Pa
Supply
Air
Grille
35 Pa
15 Pa MAL
25 Pa
COB
Production
Passage
Compression
Cubicle
Working document QAS/15.639/Rev.1
page 29
Supply
Air
Grille
30 Pa
15 Pa
Compression
Cubicle
591 Figure 7. Example of compression cubicle without change room and MAL,
592 for lower risk materials (inclusion of airlocks dependant on risk assessment)
593593
594 Note the supply air from the ceiling towards the front of the cubicle and air
595 extract at low level at the back corners of the cubicle.
596596
Production
Passage
Working document QAS/15.639/Rev.1
page 30
5975
9
7
5985
9
8
5995
9
9
6006
0
0
6016
0
1
6026
0
2
6036
0
3
6046
0
4
6056
0
5
606606
607607
608608
609609
610610
611611
612612
613613
614614
615615
616616
Working document QAS/15.639/Rev.1
page 31
Material Flow Material Flow
Wash Bay
25 Pa
Material Flow Material Flow
Equipment
Drying
45 Pa
35 Pa
Fig
ure
8.
Ex
am
ple
of
wa
sh-
bay
suit
e
5. D
E
S
I
G
N
O
F
H
V
A
C
SYSTEMS AND COMPONENTS
5.1. General
5.1.1. The required degree of air cleanliness in most non-sterile dosage
form manufacturing facilities can normally be achieved without the use of
high-efficiency particulate air (HEPA) filters, provided the air is not
recirculated or in the case of a single-product facility. Many open product
zones of non-sterile dosage form facilities are capable of meeting ISO
14644-1 Class 8 or Grade D, “at-rest” condition, measured against particle
sizes of 0.5 µm and 5 µm, but cleanliness may not necessarily be classified
as such by manufacturers.
Grade D conditions usually have a maximum viable particle concentration of
200 cfu/m3
. Alternative microbiological levels as per the table below could be
used depending on risk assessments.
15 Pa
30 Pa
Material
Flow
Production
Passage
Dirty
Equipment
Store
Clean Equipment
Store
Working document QAS/15.639/Rev.1
page 32
6176
1
7
6186
1
8
6196
1
9
6206
2
0
6216
2
1
6226
2
2
6236
2
3
6246
2
4
6256
2
5
6266
2
6
6276
2
7
6286
2
8
6296
29
630630
631631
632632
633633
634634
635635
636636
637637
638638
639639
640640
641641
642642
643643
644644
645645
646646
647647
648648
Working document QAS/15.639/Rev.1
page 33
T
a
b
l
e
1
.
M
i
c
r
o
b
i
o
l
o
g
i
c
a
l
a
i
r
q
u
a
l
i
t
y
i
n
p
r
oduction premises for the manufacture ofnon-sterile medicinal products
Area Limits
in operation
Limits
at rest
Routine
monitoring
frequency of
testing
Manufacture of
nonsterile,
semi-solid4
and
liquid dosage
forms2
Alert limit
(cfu1
/m3)
Action
limit
(cfu/m3)
(cfu/m3)
250 500 100 Weekly
Manufacture of
tablets, capsules
and coated
tablets3
500 800 400 Monthly
1
Colony-formingunit.
2
In analogy toWHO GMP guidelines, this area can alsobe classifiedas grade E.
3
In analogy toWHO GMP guidelines, this area canalso be classifiedas grade F.
4 Dependingon the product properties it maybe necessarytodefinestricter limits for water-basedsemi-solid
dosage.
5.1.2. A risk assessment should be carried out to determine the room
cleanliness conditions required and the extent of validation required. Once
room cleanliness and environmental conditions have been determined,
qualification of these conditions should be carried out.
5.1.3. There are two basic concepts of air delivery to pharmaceutical
production facilities: a recirculation system; and a full fresh air system
(100% outside air supply). For recirculation systems the amount of fresh air
should not be determined arbitrarily on a percentage basis but, for example,
by the following criteria:
 sufficient fresh air to compensate for leakage from the facility and
loss through exhaust air systems;
 sufficient fresh air to comply with national building regulations
(depends on occupant density);
 sufficient fresh air for odour control;
 sufficient fresh air to provide the required building pressurization.
5.1.4. Where automated monitoring systems are used, these should be
capable of indicating any out-of-specification (OOS) condition by means of
an alarm or similar system. Sophisticated computer-based data monitoring
systems may be installed, which can aide with planning of preventive
maintenance and can also provide trend logging.
Working document QAS/15.639/Rev.1
page 34
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
(This type of system is commonly referred to as a building management
system (BMS), building automation system (BAS) or system control and
data acquisition (SCADA) system. If these systems are used for critical
decision-making, they should be validated. If the BMS is not validated in
full (or in part for these critical parameters), an independent validated
environmental monitoring system (EMS) should be provided, specifically
for recording and alarming critical parameters. The EMS for monitoring of
critical parameters could be a computerized system or a more manual
means of recording data. Critical parameters could include, for example,
room temperature in production areas, humidity, differential pressures, fan
failure alarms, etc.)
5.1.5. Failure of a supply air fan, return air fan, exhaust air fan or dust
extract system fan can cause a system imbalance, resulting in a pressure
cascade malfunction with a resultant airflow reversal.
5.1.6. Appropriate alarm systems should be in place to alert personnel if a
critical fan fails. Critical alarms should be easily identifiable and visible
and/or audible to relevant personnel. There should be an action plan for such
alarms i.e. stop production, close up open product, move product, etc., and may
include corrective and preventive action (CAPA).
5.1.7. Based on a risk assessment a fan interlock failure matrix should be
set up, such that if a fan serving a high pressure zone fails, then any fans
serving surrounding lower pressure areas should automatically stop, to
prevent an airflow reversal and possible cross-contamination. This fan stop-
start matrix should apply to the switching on and switching off of systems
to ensure that there is no flow reversal causing cross-contamination. The
effect of fan failure on building and HVAC components should also be
assessed. A failure of one fan could cause excessive positive or negative
pressures resulting in damage such as structural failure of components.
5.1.8. Materials for components of an HVAC system should be selected
with care so that they do not become a source of contamination. Any
component with the potential for liberating particulate or microbial
contamination into the airstream should be located upstream of the final
filters.
5.1.9. Where possible ventilation dampers, filters and other services should
be designed and positioned so that they are accessible from outside the
manufacturing areas (service voids or service corridors) for maintenance
purposes.
Working document QAS/15.639/Rev.1
page 35
R
Room with
ceiling return air
S R
ROOM 2
AIR HANDLING UNIT
-
S = Supply Air
R = Return Air
F = Fresh Air
F
R S
S
+
R
+
S
Room with low
level return air
R
R ROOM 1 R
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
5.2. Air distribution
5.2.1. The positioning of supply and extract grilles should be such as to
provide effective room flushing. Low-level return or exhaust air grilles are
usually preferred. However, where this is not possible, a higher air change
rate may be needed to achieve a specified clean area condition, e.g. where
ceiling return air grilles are used.
5.2.2. There may be alternative locations for return air leaving the room.
For example, referring to Figure 9, room 1 (low-level return air) and room 2
(ceiling return air).
Figure 9. Air-handling system with high-efficiency particulate air filters in
air-handling unit
708
709
710 The airflow schematics of the two systems (Figures 9 and 10 ) indicate
711 air-handling units with return air or recirculated air, having a percentage
712 of fresh air added. Depending on product characteristics and dust loading
713 it is sometimes preferable to fit filters on return air outlets or in return air
714 ducting.
715
716
Primary
Filter
Cooling
Coil
Supply
Air
Fan
Secondary
Filter
HEPA
Filter
Working document QAS/15.639/Rev.1
page 36
AIR HANDLING UNIT
-
S = Supply Air
R = Return Air
F = Fresh Air
F
S
R
S
R
+ +
+
S S
R
HEPA Filters
S
S
Room with low
level return air
S
R S
Room with
Horizontal UDAF
Room with
Vertical UDAF
R
R
R
ROOM 4 ROOM 5
ROOM 3
717
718
719
720
721
722
723
724
725
726
727
728
729
Figure 10 is a schematic diagram of an air-handling system serving
rooms with horizontal unidirectional flow, vertical unidirectional flow and
turbulent flow, for rooms 3, 4 and 5, respectively. In this case the HEPA
filters are terminally mounted at the rooms and not in the AHU. Terminally
mounted supply air HEPA filters can assist with preventing cross-
contamination from room to room in the event of a fan failure condition.
The decision whether to install terminal HEPA filters should be based on a
risk-assessment study.
Figure 10. Horizontal unidirectional flow, vertical unidirectional flow and
turbulent flow
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
5.3. Recirculation system
5.3.1. The risk of contamination and/ or cross-contamination (including
by fumes and volatiles) due to recirculation of air should be evaluated to
determine if recirculation of air is acceptable.
5.3.2. Depending on the airborne contaminants in the return-air system
it may be acceptable to use recirculated air, provided that HEPA filters
are installed in the supply air stream (or return air stream) to remove
contaminants and thus prevent cross-contamination. The HEPA filters for
this application should have an EN 1822 classification of H13.
5.3.3. HEPA filters may not be required where the air-handling system
is serving a single product facility and there is evidence that cross-
contamination would not be possible.
5.3.4. Recirculation of air in areas where pharmaceutical dust is not
HEPA
Filters
Primary
Filter
Cooling
Coil
Supply
Air
Fan
Sec
o
n
d
a
r
y
Filter
Working document QAS/15.639/Rev.1
page 37
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
generated such as secondary packing, may not require HEPA filters in the
system.
5.3.5. HEPA filters may be located in the air-handling unit or placed
terminally. Where HEPA filters are t erminall y mounted t hey
should preferably not be connected to the ducting by means of flexible
ducting. Due to the high air pressure required for the terminal filter, this
connection should preferably be a rigid duct connection. Where flexible
ducting is used, it should be as short as possible and properly fixed to
withstand duct pressure.
When HEPA filters are terminally mounted, it should be possible to carry
out filter integrity tests from within the room. The filter housings will
therefore require ports for measuring appropriate upstream concentration
(refer to ISO 14644.3) and penetration concentration from within the room.
In addition it should be possible to measure the filter pressure drop in
individual HEPA filters by means of test ports provided.
5.3.6. Air containing solvents or flammable vapours should not be recirculated
to the HVAC system. Air containing dust from highly toxic processes should only
be recirculated if risk assessments shows adequate protection and special
precautions are in place (e.g. triple HEPA filtration).
5.4. Full fresh-air systems
5.4.1. The required degree of filtration of the exhaust air depends on the
exhaust air contaminants and local environmental regulations. HEPA filters
in the exhaust system would normally only be required when handling
hazardous materials.
Figure 11 indicates a system operating on 100% fresh air and would
normally be used in a facility dealing with toxic products or solvents, where
recirculation of air with contaminants should be avoided.
Working document QAS/15.639/Rev.1
page 38
AIR HANDLING UNIT
-
S = Supply Air
R = Return Air
F = Fresh Air
E = Exhaust Air
F
Fresh Air
S
+
S
PRODUCTION
FACILITY
EXHAUST AIR HANDLING UNIT
E E
E
Exhaust Air
Degree of filtration required
depends on exhaust air contaminants
785
786
787
Figure 11. Full fresh-air system
788
789
790
791
792
793
794
795
796
797
798
799
800
Note: A HEPA filter on supply air is optional for a full fresh-air system.
A HEPA filter on the exhaust air is dependent on type of contaminants in the
exhaust leaving the room.
5.4.2. Energy-recovery wheels if used in multiproduct facilities should
have been subjected to a risk assessment to determine if there is any
risk of cross-contamination. When such wheels are used they should
not become a source of possible contamination (see Figure 12).
Note: Alternatives to the energy-recovery wheels, such as crossover plate
heat exchangers and water-coil heat exchangers, may be used in
multiproduct facilities.
Primary
Filter
Cooling
Coil
Exhaust
Air
Fan
Supply
Air
Fan
HEPA
Filter
Secondary
Filter
Secondary
Filter
Primary
Filter
HEPA
Filter
Working document QAS/15.639/Rev.1
page 39
801
802
Figure 12. Full fresh-air system with energy recovery
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
5.4.3. The potential for air leakage between the supply air and exhaust air
as it passes through the wheel should be prevented. The relative pressures
between supply and exhaust air systems should be such that the exhaust air
system operates at a lower pressure than the supply system.
5.5. Additional system components
5.5.1. A schematic diagram of the airflow for a typical system serving a
low relative humidity suite is represented in Figure 13. Air can be dried
with a chemical drier (e.g. a rotating desiccant wheel which is continuously
regenerated by means of passing hot air through one segment of the wheel).
Alternative methods of drying air are also available.
AIR HANDLING UNIT
S = Supply Air
R = Return Air
F = Fresh Air
E = Exhaust Air
F
+
S
Energy
Recovery
Wheel
PRODUCTION
FACILITY
E
Exhaust Air
EXHAUST AIR FILTER UNIT
E E
Degree of filtration required
depends on exhaust air contaminants
-
Primary
Filter
Exhaust
Air
Fan
Fresh
Air
Cooling
Coil
HEPA
Filter
Supply
Air
Fan
Secondary
Filter
Primary
Filter
Secondary
Filter
HEPA
Filter
Working document QAS/15.639/Rev.1
page 40
CHEMICAL DRIER UNIT
Reactivation Chemical Drier
Air Fan Desiccant Wheel
E Fresh Air
S = Supply Air
R = Return Air
F = Fresh Air
E = Exhaust Air
AIR HANDLING UNIT
-
F
S
R
+
S
LOW HUMIDITY
PRODUCTION
FACILITY
R R
R
820
821
Figure 13. Air-handling system with chemical drying
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
5.5.2. The figure illustrates the chemical drier handling part of the fresh
air/return air mixture on a bypass flow. The location of the chemical drier
should be considered in the design phase. The practice of locating the
complete chemical drier unit in the production cubicle is not recommended
as this could be a source of contamination or cross-contamination. Examples
of appropriate locations for the drying wheel could include:
— full flow of fresh/return air;
— partial handling of fresh/return air (bypass airflow);
— return air only;
— fresh air only; or
— pre-cooled air with any of the above alternatives.
5.5.3. Possible additional components that may be required in air handling
should be considered depending on the climatic conditions and locations.
These may include items such as:
P
ri
m
a
ry
Filter
Process
A
i
r
Fan
R
e
a
cti
va
tion
H
e
a
te
r
+
P
ri
m
a
ry
Filter
C
o
o
l
i
n
g
Coil
S
u
p
ply
Air
Fa
n
Secondary
Fi
l
te
r
H
E
P
A
Fi
l
te
r
841 ‒ frost coils on fresh air inlets in very cold climates to preheat the air;
842 ‒ reheaters for humidity control;
843 ‒ automatic air volume control devices;
844 ‒ sound attenuators;
Working document QAS/15.639/Rev.1
page 41
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
– snow eliminators to prevent snow entering air inlets and
blocking airflow;
– dust eliminators on air inlets in arid and dusty locations;
– moisture eliminators in humid areas with high rainfall;
– fresh air precooling coils for very hot or humid climates.
– Air-handling units should be provided with adequate drains to remove
condensate.
6. PROTECTION
6.1. Products and personnel
6.1.1. Areas for the manufacture of pharmaceuticals, where pharmaceutical
starting materials and products, utensils, primary packing materials and
equipment are exposed to the environment, should be defined as “clean
areas”, “clean zones”, “controlled areas” or “cleanrooms”.
6.1.2. The achievement of a particular clean area condition depends on a
number of criteria that should be addressed at the design and qualification
stages. A suitable balance between the different criteria will be required in
order to create an efficient clean area.
6.1.3. Some of the basic criteria to be considered which affects room
cleanliness should include:
• building finishes and structure;
• dust control and containment;
• air filtration;
• air change rate or flushing rate;
• air flow pattern;
• recovery capability;
• room pressure;
• location of air terminals and directional airflow;
• temperature;
• relative humidity;
• material flow;
• personnel flow;
• gowning procedures;
• equipment movement;
• process being carried out (open or closed system);
• outside air conditions;
• occupancy;
• type of product;
• cleaning standard operating procedures (SOPs).
Working document QAS/15.639/Rev.1
page 42
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
6.1.4. Air filtration and air change rates should be set to ensure that the
defined room conditions are attained.
6.1.5. The air change rates should be determined by the manufacturer and
designer, taking into account the various critical parameters using a risk-
based approach with due consideration of capital and running costs and
energy usage. Primarily the air change rate should be set to a level that will
achieve the required room condition.
6.1.6. Air change rates are normally determined by the following
considerations (could normally vary between 10 and 20 air changes per
hour):
 area condition required: whether a specific room cleanliness
condition is in fact required and whether the room condition is
rated for an “at rest” condition or an “operational” condition (air
change rate should be selected on need rather than tradition);
 the product characteristics (e.g. odours, hygroscopicity, etc.);
 the quality and filtration of the supply air;
 particulates generated by the manufacturing process;
 particulates generated by the operators;
 configuration of the room and air supply and extract locations;
 sufficient air to achieve containment effect and to flush the area;
 sufficient air to cope with the room heat load;
 sufficient air to balance extract rates;
 sufficient air to maintain the required room pressure.
6.1.7. If a cleanroom classification is specified, the manufacturer should
state if the classification is rated for the “as-built” (Figure 14), “at-rest”(Figure
15) or “operational” (Figure 16) conditions.
6.1.8. Room classification tests in the “as-built” condition should be
carried out on the bare room, in the absence of any equipment if feasible.
Due to equipment size the rooms are constructed around the equipment and
therefore the equipment is included in the “as-built” condition.
6.1.9. Room classification tests in the “at-rest” condition should be carried
out with the equipment operating where relevant, but without any operators.
Because of the amounts of dust usually generated in a solid dosage facility,
the clean area classifications would be rated for the “at-rest” condition.
Working document QAS/15.639/Rev.1
page 43
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
6.1.10. Room classification tests in the “operational” condition are
normally carried out during the normal production process with equipment
operating and the normal number of personnel present in the room. When
qualifying for the operational condition details of the process operating,
number and positions of staff should be stipulated for each room, to enable
future qualifications to duplicate the same conditions.
6.1.11. Room recovery tests are performed to determine whether the
installation is capable of returning to a specified cleanliness level,
temperature, humidity, microbial limits, room pressure, etc. where
appropriate, within a finite time. This test is carried out after the above
room conditions have reached an OOS state after the HVAC system has
been switched off. Room recovery tests should demonstrate a reduction in
particle concentration by a factor of 100 within the prescribed time (as per
ISO 14644-3 clause B.12) (3). The guidance time period for recovery is
about 15 to 20 minutes.
In some instances it is not possible to increase the particle concentration by
a factor of 100 (such as for an ISO 14644 Class 8 condition) as the high
particle concentration can damage the particle counter. In this instance the
particle decay method can be used as per ISO 14644-3 clause B.12.3.2.
Risk assessments should be carried out to determine which rooms should
be subject to recovery tests. Recovery tests are also required to determine
how long it takes for specified conditions to be achieved after power
failure or system start up.
6.1.12. Materials and products should be protected from contamination
and cross-contamination during all stages of manufacture (see also section
6.5 for cross-contamination control).
Note: contaminants may result from inappropriate premises (e.g. poor design,
layout or finishing), poor cleaning procedures, contaminants brought in by
personnel, poor manufacturing process and a poor HVAC system.
Working document QAS/15.639/Rev.1
967
968
969
970
971
972
973
974
Figure 14. “As-built” condition
Figure 15. “At-rest” condition
page 35
Working document QAS/15.639/Rev.1
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
page 36
Figure 16. “Operational” condition
6.1.13. Airborne contaminants should be controlled through effective
ventilation and filtration.
6.1.14. External contaminants should be removed by effective filtration of
the supply air.
6.1.15. Airborne particulates and the degree of filtration should be
considered critical parameters with reference to the level of product
protection required.
6.1.16. Internal contaminants should be controlled by dilution and
flushing of contaminants in the room, or by displacement airflow (see
Figures 10, 17 and 21 for examples of methods for the flushing of
airborne contaminants).
6.1.17. The level of protection and air cleanliness for different areas should
be determined according to the product being manufactured, the process
being used and the product’s susceptibility to degradation (Table 3).
Working document QAS/15.639/Rev.1
page 37
999
1000
1001
1002
1003
1004
1005
1006
1007
1008
1009
1010
1011
1012
1013
1014
1015
1016
1017
1018
1019
1020
1021
6.2. Air filtration and air patterns
Note: The degree to which air is filtered plays an important role in the
prevention of contamination and the control of cross-contamination.
6.2.1. The type of filters required for different applications depends on
the quality of the ambient air and the return air (where applicable) and
also on the air change rates. Table 4 gives the recommended filtration
levels for different levels of protection in a pharmaceutical facility.
Manufacturers should determine and prove the appropriate use of
filters.
6.2.2. Filter classes should always be linked to the standard test method
because referring to actual filter efficiencies can be very misleading (as
different test methods each result in a different efficiency value for the
same filter). (Referring to filter classifications such as an 85% filter or a 5 μm
filter are not valid classifications and should not be used, as this can lead to
the incorrect filter being installed. Only the EN 779 and EN 1822 or ISO
29463 classifications, or ASHRAE Merv classifications, as per Tables 1 and
2, should be used.)
Working document QAS/15.639/Rev.1
page 38
1022
1023
1024
1025
1026
Table 2. Comparison of filter test standards
Eurovent 4/5
rating
ASHRAE
52.2
Eurovent 4/5
ASHRAE
52.1
BS6540 Part
1
Eurovent
4/5
ASHRAE
52.1
BS6540
Part 1
EN 779 & EN 1822
ISO
29463
(superseded)
Merv
rating
Average
arrestance
Am (%)
Average
dust spot
efficiency
Em (%)
MPPS integral
overall
efficiency (%)
EN rating
99.999995 U17
EN
1822:
2009
75E
99.99995 U16 65E
EU 14 99.9995 U15 55E
EU 13 Merv 18 99.995 H14 45E
EU 12 Merv 17 99.95 H13 35E
EU 11 99.5 E12 25E
EU 10 95 E11 15E
EU 9 Merv 16 >95 85 E10
EU 9 Merv 15 95 F9
EN
779:
2012
EU 8 Merv 14 90
MPPS =
most
penetrating
particle size
F8
Merv 13 >98 85 F7
EU 7 >98 80
Merv 12 >95 75
EU 6 >95 70 M6
Merv 11 >95 65
>95 60
Merv 10 >95 55
EU 5 Merv 9 >95 50 M5
Merv 8 >95 45
>95 40
Merv 7 >90 35
EU 4 >90 30 G4
Merv 6 90 25
EU 3 Merv 5 85 20 G3
80 <20
Merv 4 75
EU 2 Merv 3 70 G2
Merv 2 65
EU 1 Merv 1 <65 G1
Note: The filter classifications referred to above relate to the
EN 1822:2009 and EN 779: 2012 test standards (EN 779 relates to filter
Working document QAS/15.639/Rev.1
page 39
1027
1028
1029
1030
1031
1032
1033
1034
1035
1036
1037
1038
1039
1040
1041
1042
1043
1044
1045
1046
1047
1048
104
59
0
classes G1 to F9 and EN 1822 relates to filter classes E10 to U17).
Most penetrating particle size (MPPS) is a means of determining HEPA
and ultra low penetration air (ULPA filter efficiencies). The MPPS is the
particle size with the highest penetration for a defined filter medium.
(MPPS integral overall efficiency is the efficiency, averaged over the
whole superficial face area of a filter element under a given operating
conditions of the filter. MPPS local efficiency is the efficiency, at a specific
point of the filter element under given operating conditions of the filter).
Note: ULPA filters are not applicable to pharmaceutical installations.
6.2.3. In selecting filters, the manufacturer should have considered other
factors, such as particularly contaminated ambient conditions, local
regulations and specific product requirements. Good prefiltration extends
the life of the more expensive filters downstream.
6.2.4. Filters have an impact on the cleanroom class or level of
protection. The different levels of protection and recommended filters
grades are given in Tables 3 and 4 below.
Table 3. Examples of levels of protection (based on ISPE oral solid dosage
(OSD) guideline criteria)
Level Condition Example of area
Level 1 General Area with normal housekeeping and
maintenance where there is no potential for
product contamination, e.g. warehousing.
Level 2 Protected Area in which steps are taken to protect
the pharmaceutical starting material or
product from direct or indirect
contamination or degradation, e.g.
secondary packing, warehousing, first
stage change rooms.
Working document QAS/15.639/Rev.1
page 40
Level 3 Controlled Area in which specific environmental
conditions are defined, controlled and
monitored to prevent contamination or
degradation of the pharmaceutical starting
material or product, e.g. where product,
starting materials and components are
exposed to the room environment; plus
equipment wash and storage areas for
equipment product contact parts.
1051
1052
1053
1054
1055
1056
1057
1058
1059
1060
1061
1062
1063
1064
1065
1066
Table 4. Levels of protection and recommended filtration
Level of protection Recommended filtration
Level 1 Primary filters only (e.g. EN 779 G4 filters)
Level 2 Protected areas operating on recirculated or full
fresh air
Primary plus secondary filters (e.g. EN 779 G4
plus F8 or F9 filters)
Level 3 Production facility operating on recirculated
plus ambient air, where potential for cross-
contamination exists: Primary plus secondary
plus tertiary filters (e.g. EN 779 G4 plus F8 plus
EN 1822 H13 filters) (for full fresh air system,
without recirculation, G4 and F8 or F9 filters are
acceptable)
6.2.5. Directional airflow within production or primary packing areas
should assist in preventing contamination. Airflows should be planned in
conjunction with operator locations, so as to minimize contamination of the
product bythe operator and also to protect the operator from dust inhalation.
An example of flushing effect with turbulent airflow and low level extract
is indicated in Figure 17 below.
6.2.6. At airlocks and change rooms supply air and extract air terminals
should be positioned such that air flows from the clean side of the room to
the less clean side, to enhance the separation between the two adjoining
rooms.
Working document QAS/15.639/Rev.1
page 41
1067
1068
1069
1070
1071
1072
1073
1074
1075
1076
1077
1078
1079
1080
1081
1082
1083
1084
1085
1086
1087
1088
1089
1090
Figure 17. Turbulent dilution of dirty air
Low-level extract is ideal for dust suppression purposes, but is not
essential where no dust is liberated. (Low-level extract is essential for
Grade C classified areas – for information only.)
6.2.7. Supply air diffusers should beselected with care taking consideration
of, e.g. room requirements and positions of equipment and operators in the
room. Supply air diffusers of the high induction type (e.g. those typically
used for office-type air-conditioning) should where possible not be used
in clean areas where dust is liberated. Air diffusers should be of the non-
induction type, introducing air with the least amount of induction so as to
maximize the flushing effect. In rooms where the process results in high
dust liberation; perforated plates or low induction swirl diffusers with
low level extract or return should be used (to contain the dust at the lower
level of the room) (see Figures 18–20 for illustrations of the three types of
diffuser). Although ceiling returns are generally avoided in cases where dust
liberation is low, ceiling return air grilles may be acceptable.
Working document QAS/15.639/Rev.1
page 42
1091
1092
1093
1094
1095
1096
1097
1098
1099
1100
1101
1102
1103
1104
1105
1106
1107
6.2.8. The type of diffusers used for each room should be carefully
selected considering their air flow patterns and the amount of dust
liberated in the room. Induction and certain swirl diffusers create good
dilution of room air and may be used where dust liberation is minimal. If
used in rooms where significant dust is generated, their use may draw dust
up into the air stream and spread it throughout the room, presenting
increased hazards to containment and to operators. Some swirl type
diffusers have less induction (as indicated in Figure 20)
6.2.9. Airflow patterns for different diffuser types are indicated in Figures
18, 19 and 20 below.
Figure 18. Induction diffuser
Working document QAS/15.639/Rev.1
page 43
1108
1109
1110
1111
1112
1113
Figure 19. Perforated plate diffuser
Figure 20. Swirl diffuser
Working document QAS/15.639/Rev.1
page 44
1114
1115
1116
1117
1118
1119
1120
1121
1122
1123
1124
1125
1126
1127
1128
1129
1130
1131
1132
1133
1134
1135
1136
1137
1138
6.3. Unidirectional airflow
6.3.1. Unidirectional airflow (UDAF) should be used for weighing booths
or sampling booths to provide operator and product protection and should
also have a slight air in-flow from the room to enhance containment. Dust
containment at the weigh booth should be demonstrated by smoke airflow
pattern tests (AFPT), or other appropriate tests. UDAF can also be used to
provide protection of other dusty processes.
6.3.2. Sampling of materials such as starting materials, primary packaging
materials and products, should be carried out in the same environmental
conditions that are required for the further processing of the product.
6.3.3. In a weighing booth situation, the aim of the UDAF is to provide
dust containment and operator protection. The weigh booth and dispensary
should have the same environmental conditions that are required for the
further processing of the product.
Example: in Figure 21 the dust generated at the weighing station is
immediately extracted through the perforated worktop, thus protecting the
operator from dust inhalation, but at the same time protecting the product
from contamination by the operator by means of the vertical unidirectional
airflow stream.
Figure 21. Operator protection at weighing station
Working document QAS/15.639/Rev.1
page 45
1139
1140
1141
1142
1143
1144
1145
1146
1147
1148
1149
1150
1151
1152
1153
1154
1155
1156
6.3.4 The unidirectional flow velocity should be such that it does not
disrupt the sensitivity of balances in weighing areas. However, the airflow
velocity and directional flow should be appropriate to ensure product
containment and operator protection. For this type of application it is
sometimes better to refer to the unit as an airflow protection booth (APB)
rather than a UDAF, in order to avoid confusion, with a Grade A
requirement. To assist with containment for weighing and sampling
operations there should be a slight inflow of air into the UDAF protected
zone from the surrounding room in order to prevent dust escaping. Thus
the amount of air extracted from below the UDAF/APB should exceed the
amount of air supplied.
6.3.5 The position in which the operator stands relative to the source of
dust liberation and airflow should be determined to ensure that the operator
is not in the path of an airflow that could lead to contamination of the
product (Figure 22).
Figure 22. Operator protection by horizontal airflow
Working document QAS/15.639/Rev.1
page 46
1157
1158
1159
1160
1161
1162
1163
1164
1165
1166
1167
1168
1169
1170
1171
1172
1173
1174
1175
6.3.6 Once the system has been designed and qualified with a specific
layout for operators and processes, this configuration should be maintained
in accordance with an SOP.
6.3.7 There should be no obstructions in the path of a unidirectional flow
air stream that may cause the operator to be exposed to dust.
Figure 23 illustrates the incorrect use of a weighing scale which has a solid
back. The back of the weighing scale should not block the return air path
as this obstructs the airflow and causes air to rise vertically carrying dust,
resulting in a hazardous situation for the operator.
Figure 24 illustrates a situation where an open bin is placed below a vertical
unidirectional airflow distributor. The downward airflow should be
prevented from entering the bin, and then being forced to rise again, as this
Working document QAS/15.639/Rev.1
page 47
1176
1177
1178
1179
1180
1181
1182
1183
1184
1185
1186
1187
would carry light dust up towards the operator’s face. In such an
occurrence it may be necessary to add a partial cover over the bin to limit
the entry of air. Point extraction could also be used but this can result in
the excessive loss of product.
Figure 25 shows that a solid worktop can sometimes cause deflection of
the vertical unidirectional airflow resulting in a flow reversal. A possible
solution would be to have a 100 mm gap between the back of the table and
the wall, with the air being extracted here, or have a perforated worktop
with extraction below..
Working document QAS/15.639/Rev.1
page 48
1188
1189
1190
1191
1192
1193
Figure 23. Operator subject to powder inhalation due to obstruction
Figure 24. Operator subject to powder contamination due to airflow
reversal in bin
Working document QAS/15.639/Rev.1
page 49
1194
1195
1196
1197
1198
1199
1200
1201
Figure 25. Operator subject to powder inhalation due to worktop
obstruction
6.3.8 The manufacturer should select either vertical or horizontal
unidirectional airflow (Figure 26), and an appropriate airflow pattern to
Working document QAS/15.639/Rev.1
page 50
1202
1203
1204
1205
1206
1207
1208
provide the best protection for the particular application.
Figure 26. Diagram indicating horizontal and vertical unidirectional flow
Working document QAS/15.639/Rev.1
page 51
1209
1210
1211
1212
1213
1214
1215
1216
1217
1218
1219
1220
1221
1222
1223
1224
1225
1226
1227
1228
1229
1230
1231
1232
1233
1234
1235
1236
1237
1238
1239
1240
1241
1242
1243
1244
1245
1246
1247
1248
1249
1250
1251
6.3.9 Return or exhaust air grilles in rooms or at weigh or sampling booths
should preferably be of the perforated grille types, which are easy to clean.
Return/exhaust air filters can either be installed at the room terminal or in
the air-handling unit. Maintenance and cleaning of filters and ducts should
be addressed to ensure constant airflow.
6.4. Infiltration
6.4.1. Air infiltration of unfiltered air into a pharmaceutical plant should
not be a source of contamination.
6.4.2. Manufacturing facilities should normally be maintained at a positive
pressure relative to the outside, to limit the ingress of contaminants. Where
facilities are to be maintained at negative pressures relative to the ambient
pressure, special precautions should be taken. Refer to the WHO
guidelines for hazardous products, for further guidance on negative
pressure facilities.
6.4.3. The location of the negative pressure facility should be carefully
considered with reference to the areas surrounding it, particular attention
being given to ensuring that the building structure is well sealed.
6.4.4. Negative pressure zones should, as far as possible, be encapsulated
by surrounding areas with clean air supplies, so that only clean air can
infiltrate into the controlled zone.
6.5. Cross-contamination and contamination
6.5.1. Where different products are manufactured at the same time, in
different areas or cubicles, in a multiproduct OSD manufacturing site,
measures should be taken to ensure that dust cannot move from one cubicle
to another.
6.5.2. Correct directional air movement and a pressure cascade system
can assist in preventing cross-contamination. The pressure cascade should
be such that the direction of airflow is from the clean corridor into the
cubicles, resulting in dust containment.
6.5.3. For cubicles where dust is liberated, the corridor should be
maintained at a higher pressure than the cubicles and the cubicles at a
higher pressure than atmospheric pressure. (For negative pressure facilities
Working document QAS/15.639/Rev.1
page 52
1252
1253
1254
1255
1256
1257
1258
1259
1260
1261
1262
1263
1264
1265
1266
1267
1268
1269
1270
1271
1272
1273
1274
1275
1276
1277
1278
1279
1280
1281
1282
1283
1284
1285
1286
1287
1288
1289
1290
1291
1292
1293
1294
1295
refer to WHO Technical Report Series, No. 957, Annex 3 for hazardous
products guidelines and design conditions.)
6.5.4. Containment can normally be achieved by application of the
pressure differential concept (high pressure differential, low airflow), or the
displacement concept (low pressure differential, high airflow), or the
physical barrier concept, as described in ISO 14644-4. However, the “low
pressure differential, high airflow” method is no longer used as a means of
room segregation.
6.5.5. The pressure cascade for each facility should be individually
assessed according to the product handled and level of protection required.
The pressure cascade regime and the direction of airflow should be
appropriate to the product and processing method used, and should also
provide operator and environmental protection.
6.5.6. Building structure should be given special attention to accommodate
the pressure cascade design.
6.5.7. Ceilings and walls, close fitting doors and sealed light fittings should
be in place, to limit ingress or egress of air.
6.6. Pressure differential concept (high pressure differential, low
airflow)
Note: The pressure differential concept may be used alone or in
combination with other containment control techniques and concepts, such
as a double door airlock.
6.6.1. The high pressure differential between the clean and less clean
zones should be generated by balancing the supply and extract air quantities in
the two adjoining rooms, thus resulting in the pressure gradient. Leakage through
the cracks around the door, as a result of the pressure differential, is acceptable.
6.6.2. The pressure differential should be of sufficient magnitude to ensure
containment and prevention of flow reversal, but should not be so high as to
create turbulence problems.
6.6.3. In considering room pressure differentials, transient variations, such
as machine extract systems, should be taken into consideration.
6.6.4. A pressure differential of 15 Pa is often used for achieving
containment between two adjacent zones, but pressure differentials of
Working document QAS/15.639/Rev.1
page 53
1296
1297
1298
1299
1300
1301
1302
1303
1304
1305
1306
1307
1308
1309
1310
1311
1312
1313
1314
1315
1316
1317
1318
1319
1320
1321
1322
1323
1324
1325
between 5 Pa and 20 Pa may be acceptable. Where the design pressure
differential is too low and tolerances are at opposite extremities, a flow
reversal can take place. For example, where a control tolerance of ± 3 Pa
is specified, the implications of adjacent rooms being operated at the upper
and lower tolerances should be evaluated. It is important to select pressures
and tolerances such that a flow reversal is unlikely to occur.
6.6.5. The pressure differential between adjacent rooms could be
considered a critical parameter, depending on the outcome of risk analysis.
The limits for the pressure differential between adjacent areas should be
such that there is no risk of overlap in the acceptable operating range, e.g.
5 Pa to 15 Pa in one room and 15 Pa to 30 Pa in an adjacent room, resulting
in the failure of the pressure cascade, where the first room is at the maximum
pressure limit and the second room is at its minimum pressure limit.
6.6.6. Low pressure differentials may be acceptable when airlocks
(pressure sinks or pressure bubbles) are used to segregate areas.
6.6.7. The effect of room pressure tolerances are illustrated in Figure 27.
If one room is at the higher side of the tolerance and the other at the lower
side of the tolerance, it could result in either a high or a low pressure
differential. When setting tolerances it is also important to specify if the
tolerance is applicable to the absolute room pressures or the pressure
differentials. In the diagram below the tolerances have been based on a ±
3 Pa tolerance on absolute room pressures, resulting in pressure
differential variances of between 21 and 9 Pa. For a room pressure
differential of 15 Pa and a tolerance based on ± 3 Pa of differential
pressure, then the resultant variances would only be between 12 and 18 Pa.
Working document QAS/15.639/Rev.1
page 54
15 Pa ± 3 Pa
Air Leak
akage
Encapsulation
15 Pa ± 3 Pa
Compression Compression
15 Pa ± 3 Pa 15 Pa ± 3 Pa
Production Corridor
30 Pa ± 3 Pa
Air Le age
Tablet Tablet
Airlock
1326 Figure 27. Examples of pressure cascades
Design Condition (15 Pa Pressure Differential)
1327
1328
Maximum Differential (21 Pa Pressure Differential) Minimum Differential (9 Pa Pressure Differential)
1329
1330
1331
1332
1333
1334
1335
1336
1337
1338
1339
1340
1341
1342
1343
1344
1345
1346
1347
1348
1349
1350
1351
6.6.8. The pressure control and monitoring devices used should be
calibrated and qualified. Compliance with specifications should be regularly
verified and the results recorded. Pressure control devices should be linked
to an alarm system set according to the levels determined by a risk analysis.
6.6.9. Manual control systems, where used, should be set up during
commissioning, with set point marked, and should not change unless other
system conditions change.
6.6.10. Airlocks can beimportant components in setting up and maintaining
pressure cascade systems and also to limit cross-contamination.
6.6.11. Airlocks with different pressure cascade regimes include the
cascade airlock, sink airlock and bubble airlock (Figures 28–30):
 cascade airlock: higher pressure on one side of the airlock and
lower pressure on the other;
 sink airlock: lower pressure inside the airlock and higher pressure on
both outer sides;
 bubble airlock: higher pressure inside the airlock and lower
pressure on both outer sides.
e age
12 Pa
Air Leak
akage
Airlock
Air L
Production Corridor
33 Pa
Encapsulation
12 Pa
Tablet
Compression
12 Pa
Tablet
Compression
12 Pa
Airlock
akage Air Leak
18 Pa
Air L
Production Corridor
27 Pa
Encapsulation
18 Pa
Tablet
Compression
18 Pa
Tablet
Compression
18 Pa
e age
Image ofroompressure gauge
indicating colour coded norm
al,
alert & action parameters
Air
Leakage
Air
Leakage
Air
Leakage
Air
Leakage
Air
Leakage
Air
Leakage
Air
Leakage
Air
Leakage
Air
Leakage
Working document QAS/15.639/Rev.1
page 55
1352
1353
1354
1355
1356
Figure 28. Example of cascade airlock
(In most cases the internal pressure of the airlock is not critical. The
pressure differential between the two outer sides is the important criteria.)
1357
1358
Air Leakage Air Leakage
15 Pa
Material Airlock
22.5 Pa
30 Pa
CascadeAirlock
Working document QAS/15.639/Rev.1
page 56
1359
1360
Figure 29. Example of sink airlock
1361
1362
Air Leakage
Air Leakage
30 Pa
Material Airlock
30 Pa
15 Pa
Sink Airlock
Working document QAS/15.639/Rev.1
page 57
1363
1364
Figure 30. Example of bubble airlock
1366
1367
1368
1369
1370
1371
1372
1373
1374
1375
1376
1377
1378
1379
1380
1381
1382
1383
1384
1385
1386
1387
Note: The diagrams above and the differential pressures shown here are
for illustration purposes only. Pressures indicated in these examples are
absolute pressures, whereas the local pressure indication would most likely
be pressure differential from room to room.
6.6.12. Doors should open to the high pressure side, so that room pressure
assists in holding the door closed and in addition be provided with self-
closers. Should the doors open to the low pressure side, the door closer
springs should be sufficient to hold the door closed and prevent the pressure
differential from pushing the door open. There should be a method to
indicate if both doors to airlocks are open at the same time, or alternatively
these should be interlocked such that only one door can be opened at a
time. The determination of which doors should be interlocked should be
the subject of a risk assessment study.
6.6.13. Risk assessment should be done to determine whether dust
extraction systems should be interlocked to the appropriate air-handling
systems. Failure to interlock fans could result in pressure cascade
imbalances.
Air Leakage
Air Leakage
15 Pa Material Airlock
30 Pa
15 Pa
Bubble Airlock
Working document QAS/15.639/Rev.1
page 58
1388
1389
1390
1391
1392
1393
1394
1395
1396
1397
1398
1399
1400
1401
1402
1403
1404
1405
1406
1407
1408
1409
1410
1411
1412
1413
1414
1415
1416
1417
1418
1419
1420
1421
1422
1423
1424
1425
1426
1427
1428
1429
6.6.14. Air should not flow through the dust extraction ducting or return
air ducting from the room with the higher pressure to the room with the
lower pressure (this would normally occur only if extract or return systems
were inoperative). Systems should be designed to prevent dust flowing back
in the opposite direction in the event of component failure or airflow failure.
6.6.15. Adequate room pressure differential indication should be provided
so that each critical room pressure can be traced back to ambient pressure
(by summation of the room pressure differentials), in order to determine the
room actual absolute pressure. A pressure gauge installed to indicate the
pressure differential from a central corridor to ambient could serve to trace
pressures to ambient.
6.6.16. Room pressure indication gauges should have a range and
graduation scale which enables the reading to an appropriate accuracy.
Normal operating range, alert and action limits should be defined and
displayed at the point of indication. A colour coding of these limits on the gauge
may behelpful.
Room pressure indication may be either analogue or digital, and may be
represented as either pressure differentials or absolute pressures.
Whichever system is used any out-of-specification (OOS) condition should
be easily identifiable. Zero setting of gauges should be frequently checked (such
as, weekly) and zero setting should preferably be tamper proof.
6.6.17. Material PTHs or pass boxes (PB) can also be used for separating
two different zones. PTHs fall into two categories, namely a dynamic PTH
or a passive PTH. Dynamic PTHs have an air supply to or extraction from
them, and can then be used as bubble, sink or cascade PTHs.
6.6.18. Room pressure differential tolerances should always be set with a
maximum and minimum tolerance. Setting tolerances as NMT or NLT can
easily lead to an OOS condition.
6.7. Physical barrier concept
6.7.1. Where appropriate, an impervious barrier to prevent cross-
contamination between two zones, such as closed manufacturing and
transfer systems, pumped or vacuum transfer of materials, should be
used.
Working document QAS/15.639/Rev.1
page 59
1430
1431
1432
1433
1434
1435
1436
1437
1438
1439
1440
1441
1442
1443
1444
1445
1446
1447
1448
1449
1450
1451
1452
1453
1454
1455
1456
1457
1458
1459
1460
1461
1462
1463
1464
1465
1466
1467
1468
1469
1470
1471
1472
1473
1474
1475
1476
1477
6.8. Temperature and relative humidity
6.8.1. Where appropriate, temperature and relative humidity should be
controlled, monitored and recorded, where relevant, to ensure compliance
with requirements pertinent to the materials and products and provide a
comfortable environment for the operator where necessary.
6.8.2. Maximum and minimum room temperatures and relative humidity
should be appropriate. Alert and action limits on temperatures and
humidities should be set, as appropriate.
6.8.3. The operating band, or tolerance, between the acceptable minimum
and maximum temperatures should not be made too close. Tight control
tolerances may be difficult to achieve and can also add unnecessary
installation and running costs.
6.8.4. Cubicles, or suites, in which products requiring low relative humidity
are processed, should have well-sealed walls and ceilings and should also
be separated from adjacent areas with higher relative humidity by means of
suitable airlocks.
6.8.5. Precautions should be taken to prevent moisture migration that
increases the load on the HVAC system.
6.8.6. Humidity control should be achieved by removing moisture from
the air, or adding moisture to the air, as relevant.
6.8.7. Dehumidification (moisture removal) may be achieved by means of
either refrigerated dehumidifiers (cooling coils) or chemical dehumidifiers.
6.8.8. Humidifiers should be avoided if possible as they may become a
source of contamination (e.g. microbiological growth). Where humidification
is required, this should be achieved by appropriate means such as the injection
of steam into the air stream. A product-contamination assessment should be
done to determine whether purified water or clean steam is required for the
purposes of humidification.
6.8.9. Humidification systems should be well drained. No condensate
should accumulate in air-handling systems.
6.8.10. Other humidification appliances such as evaporative systems,
atomizers and water mist sprays, should not be used because of the potential
risk of microbial contamination.
6.8.11. Duct material in the vicinity of the humidifier should not add
contaminants to air that will not be removed byfiltration further downstream.
Working document QAS/15.639/Rev.1
page 60
1478
1479
1480
1481
1482
1483
1484
1485
1486
1487
1488
1489
1490
1491
1492
1493
1494
1495
1496
1497
1498
1499
1500
1501
1502
1503
1504
1505
1506
1507
1508
1509
1510
1511
1512
1513
1514
1515
1516
1517
1518
1519
1520
1521
1522
1523
1524
6.8.12. Air filters should not be installed immediately downstream of
humidifiers, as moisture on the filters could lead to bacterial growth.
6.8.13. Cold surfaces should be insulated to prevent condensation within
the clean area or on air-handling components.
6.8.14. When specifying relative humidity, the associated temperature
should also be specified.
6.8.15. Chemical driers using silica gel or lithium chloride are acceptable,
provided that they do not become sources of contamination.
7. DUST CONTROL
7.1. Wherever possible, dust or vapour contamination should be
removed at source. Point-of-use extraction, i.e. as close as possible to the
point where the dust is generated, should be employed. Spot ventilation or
capture hoods may be used as appropriate. The HVAC system should not
serve as the primary mechanism of dust control.
7.2. Point-of-use extraction should be either in the form of a fixed,
high-velocity extraction point or an articulated arm with movable hood or a
fixed extraction hood. Care should be taken in the design and positioning of
dust extract points to prevent cross-contamination by powders dropping down
from the extract point.
7.3. Dust extraction ducting should be designed with sufficient transfer
velocity to ensure that dust is carried away, and does not settle in the ducting.
Periodic checks should be performed to ensure that there is no build-up of
the dust in the ducting.
7.4. The required transfer velocity should be determined: it is dependent
on the density of the dust (the denser the dust, the higher the transfer
velocity should be, e.g. 15–20 m/s).
7.5. Airflow direction should be carefully chosen, to ensure that the
operator does not contaminate the product, and also so that the operator is
not put at risk by the product.
7.6. Point extraction alone is usually not sufficient to capture all of
the contaminants, and general directional airflow should be used to assist
in removing dust and vapours from the room.
7.7. Typically, in a room operating with turbulent airflow, the air should
be introduced from ceiling diffusers, located at the door entry side of the
room and extracted from the rear of the room at low level to help give a
Working document QAS/15.639/Rev.1
page 61
1525
1526
1527
1528
1529
1530
1531
1532
1533
1534
1535
1536
1537
1538
1539
1540
1541
1542
1543
1544
1545
1546
1547
1548
1549
1550
1551
1552
1553
1554
1555
1556
1557
1558
1559
1560
1561
1562
1563
1564
1565
1566
1567
1568
flushing effect in the room. Correct flushing of the rooms may be verified
by airflow visualization smoke tests.
7.8. When dealing with particularly harmful products, additional steps,
such as handling the products in glove boxes or using barrier isolator
technology, should be used (refer to WHO Technical Report Series, No.
957, Annex 3 for additional guidance on handling hazardous products).
8. PROTECTION OF THE ENVIRONMENT
8.1. General
8.1.1. It should benoted that protection of the environment is not addressed
in this guideline, and discharges into the atmosphere should be compliant
with relevant local and national environmental legislation and standards.
8.1.2. Dust, vapours and fumes could be possible sources of contamination;
therefore, care should be taken when deciding on the location of the inlet
and exhaust points relative to one other.
8.2. Dust in exhaust air
8.2.1. Exhaust air discharge points on pharmaceutical equipment and
facilities, such as from fluid bed driers and tablet-coating equipment, and
exhaust air from dust extraction systems, carry heavy dust loads and should be
provided with adequate filtration to prevent contamination of the ambient air.
8.2.2. Where the powders are not highly potent, final filters on a dust
exhaust system should be fine dust filters with a filter classification of F9
according to EN 779 filter standards.
8.2.3. Where reverse-pulse dust collectors are used for removing dust from
dust extraction systems, they should usually be equipped with cartridge
filters containing a compressed air lance, and be capable of continuous
operation without interrupting the airflow.
8.2.4. Alternative types of dust collectors (such as those operating with a
mechanical shaker, requiring that the fan be switched off when the mechanical
shaker is activated) should be used in such a manner that there is no risk
of cross-contamination. There should be no disruption of airflow during a
production run as the loss of airflow could disrupt the pressure cascade.
8.2.5. Mechanical-shaker dust collectors should not beused for applications
where continuous airflow is required, in order to avoid unacceptable
Working document QAS/15.639/Rev.1
page 62
1569
1570
1571
1572
1573
1574
1575
1576
1577
1578
1579
1580
1581
1582
1583
1584
1585
1586
1587
1588
1589
1590
1591
1592
1593
1594
1595
1596
1597
1598
1599
1600
1601
1602
1603
1604
1605
1606
1607
1608
1609
1610
1611
1612
1613
1614
1615
fluctuations in room pressures, except in the case where room pressures are
automatically controlled.
8.2.6. When wet scrubbers are used, the dust-slurry should be removed by
a suitable means, e.g. a drainage system or waste removal contractor.
8.2.7. The quality of the exhaust air should be determined to see whether the
filtration efficiency is adequate with all types of dust collectors and wet
scrubbers.
8.2.8. Where necessary, additional filtration may be provided downstream
of the dust collector.
8.3. Vapour and fume removal
8.3.1. Vapour should be extracted at the point of generation. When planning
the system for the extraction of residual vapours, the density of the vapour
should be taken into account. If the vapour is lighter than air, the extract
grilles should be at a high level, or possibly at both high and low levels.
8.3.2. The systems for fume, dust and effluent control should be designed,
installed and operated in such a manner that they do not become possible
sources of contamination or cross-contamination, e.g. an exhaust-air
discharge point located close to the HVAC system fresh air inlet.
8.3.3. Fumes should be removed by means of wet scrubbers or dry
chemical scrubbers (deep-bed scrubbers).
8.3.4. Wet scrubbers for fume removal normally require the addition of
various chemicals to the water to increase the adsorption efficiency.
8.3.5. Deep-bed scrubbers should be designed with activated carbon filters
or granular chemical adsorption media. The chemical media for deep-bed
scrubbers should be specific to the effluent being treated.
8.3.6. The type and quantity of the vapours to be removed should be
known to enable the appropriate filter media, as well as the volume of media
required to be determined.
9. COMMISSIONING, QUALIFICATION AND VALIDATION
9.1. General
9.1.1. The HVAC system plays an important role in the protection of the
product, the personnel and the environment.
Working document QAS/15.639/Rev.1
page 63
1616
1617
1618
1619
1620
1621
1622
1623
1624
1625
1626
1627
1628
1629
1630
1631
1632
1633
1634
1635
1636
1637
1638
1639
1640
1641
1642
1643
1644
1645
1646
1647
1648
1649
1650
1651
1652
1653
1654
1655
1656
9.1.2. For all HVAC installation components, subsystems or parameters,
critical parameters and non-critical parameters should be determined.
9.2. Commissioning
9.2.1. Commissioning should involve the setting up, balancing,
adjustment and testing of the entire HVAC system, to ensure that the
system meets all the requirements, as specified in the user requirement
specification, and capacities as specified by the designer or developer. The
commissioning plan should start at the early stages of a project so that it
can be integrated with qualification and verification procedures.
9.2.2. Acceptable tolerances for all system parameters should be specified
and agreed by the user prior to commencing the physical installation.
These tolerances should be specified in the user requirement specifications
9.2.3. Acceptance criteria should be set for all system parameters. The
measured data should fall within the acceptance criteria.
9.2.4. System installation records should provide documented evidence
of all measured capacities of the system.
9.2.5. The i n s t al l at i o n r e co r ds should include items such as the
design and measured figures for airflows, water flows, system pressures
electrical amperages, etc. These should be contained in the operating
and maintenance manuals (O & M manuals). The installation records of
the system should provide documented evidence of all measured capacities
of the system.
9.2.6. Typical information that should be contained in the O&M
manuals is the following:
 system description;
 operating instructions;
 trouble shooting;
 commissioning data schedules;
 maintenance instructions;
 list of equipment suppliers;
 spare parts lists;
 equipment capacity and data schedules;
 supplier’s literature;
Working document QAS/15.639/Rev.1
page 64
System 2
System 1
Process
A number of Qualified systems make up a Validated process.
1657  control system operation;
1658  electrical drawings;
1659  as-built drawings;
1660  maintenance records.
1661
1662 9.2.7. O & M manuals, schematic drawings, protocols and reports should
1663
1664
1665
1666
1667
1668
1669
1670
1671
1672
1673
1674
1675
1676
1677
1678
1679
1680
1681
1682
1683
1684
1685
be maintained as reference documents for any future changes and upgrades
to the system. As-built drawings should be available and should be kept up
to date with all the latest system changes. Any changes from the originally
approved system should be covered by change control documentation and
risk assessment studies where deemed necessary.
9.2.8. Training should be provided to personnel after installation of the
system, and should include how to perform operation and maintenance.
9.2.9. Commissioning should be a precursor to system qualification and
validation.
9.3. Qualification
9.3.1. Manufacturers should qualify HVAC systems using a risk-based
approach. The basic concepts of qualification of HVAC systems are set out
in Figure 31 below.
Figure 31. Qualification is a part of validation
Equipment Equipment Equipment Equipment Equipment Equipment Equipment
1 2 3 4 5 6 7
9.3.2. The qualification of the HVAC system should be described in a
validation master plan (VMP), or a subsection of the VMP.
Qualification
Validation
Working document QAS/15.639/Rev.1
page 65
1686
1687
1688
1689
1690
1691
1692
1693
1694
1695
1696
1697
1698
9.3.3. The VMP should define the nature and extent of testing and the test
procedures and protocols to be followed.
9.3.4. Stages of the qualification of the HVAC system should include
design qualification (DQ), installation qualification (IQ), operational
qualification (OQ) and performance qualification (PQ). The relationship
between the development stage of a project (user requirement
specification, functional design specification, detail design and
configuration specifications, build & project implementation) and the
qualification stages are given in the V-diagram (Figure 32) below. The V-
model is one example of an approach to qualification and validation.
Figure 32.
V-Model for Direct Impact Systems
User Requirement
Specification
Functional Design
Specification
Detail Design and
Configuration
Specifications
PQ Test Plan
(incl. UAT)
OQ Test Plan
(incl. SAT)
IQ Test Plan
(incl. FAT/PDI)
Performance
Qualification
Operational
Qualification
Installation
Qualification
Build & Project
Implementation
1699
1700
1701
1702
1703
1704
1705
SAT, FAT & PDI where applicable, could take place at different stages depending on the application
UAT=user acceptance tests; FAT=factory acceptance tests; SAT=site
acceptance tests; PDI=pre-delivery inspections.
9.3.5. Critical and non-critical parameters for all HVAC installation
components, subsystems and controls should be determined by means of a
risk analysis.
DQ Test Plan
Design
Qualification
Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng
Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng
Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng
Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng
Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng
Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng
Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng
Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng
Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng
Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng
Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng

More Related Content

Similar to Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng

Generalguidanceholdtimeqas13 521rev320augskclean 2
Generalguidanceholdtimeqas13 521rev320augskclean 2Generalguidanceholdtimeqas13 521rev320augskclean 2
Generalguidanceholdtimeqas13 521rev320augskclean 2cubi333
 
generalguidanceholdtimeqas13-521rev320augskclean
generalguidanceholdtimeqas13-521rev320augskcleangeneralguidanceholdtimeqas13-521rev320augskclean
generalguidanceholdtimeqas13-521rev320augskcleanGoutam Dutta
 
WHO Good Practices for Pharmaceutical Microbiology Laboratories
 WHO Good Practices for Pharmaceutical Microbiology Laboratories WHO Good Practices for Pharmaceutical Microbiology Laboratories
WHO Good Practices for Pharmaceutical Microbiology LaboratoriesPostgradoMLCC
 
WHO Guideline on Quality Risk Management
WHO Guideline on Quality Risk Management WHO Guideline on Quality Risk Management
WHO Guideline on Quality Risk Management PostgradoMLCC
 
Carbon Footprinting and Healthcare
Carbon Footprinting and HealthcareCarbon Footprinting and Healthcare
Carbon Footprinting and HealthcareUNDP Eurasia
 
PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)Swathi P
 
Pe 009 13 gmp guide (x annexes)
Pe 009 13 gmp guide (x annexes)Pe 009 13 gmp guide (x annexes)
Pe 009 13 gmp guide (x annexes)Salah T
 
3-ICH-guidelines-6th-Sem.pdf
3-ICH-guidelines-6th-Sem.pdf3-ICH-guidelines-6th-Sem.pdf
3-ICH-guidelines-6th-Sem.pdfPrathikshakotari
 
NICE scientific advice between 2009 and 2015
NICE scientific advice between 2009 and 2015NICE scientific advice between 2009 and 2015
NICE scientific advice between 2009 and 2015Francois MAIGNEN
 
1978237935_WHOGMP_ICH.ppt
1978237935_WHOGMP_ICH.ppt1978237935_WHOGMP_ICH.ppt
1978237935_WHOGMP_ICH.pptssuser868fa0
 
Demo of NABH Documentation Kit for Pre Accreditation
Demo of NABH Documentation Kit for Pre AccreditationDemo of NABH Documentation Kit for Pre Accreditation
Demo of NABH Documentation Kit for Pre AccreditationGlobal Manager Group
 
OHE Lunchtime Seminar: Health Technology Assessment Scientific and Outcomes A...
OHE Lunchtime Seminar:Health Technology Assessment Scientific and Outcomes A...OHE Lunchtime Seminar:Health Technology Assessment Scientific and Outcomes A...
OHE Lunchtime Seminar: Health Technology Assessment Scientific and Outcomes A...Office of Health Economics
 

Similar to Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng (20)

Comments on the Supplementary Guidelines on Good Manufacturing Practices for...
Comments on the  Supplementary Guidelines on Good Manufacturing Practices for...Comments on the  Supplementary Guidelines on Good Manufacturing Practices for...
Comments on the Supplementary Guidelines on Good Manufacturing Practices for...
 
Generalguidanceholdtimeqas13 521rev320augskclean 2
Generalguidanceholdtimeqas13 521rev320augskclean 2Generalguidanceholdtimeqas13 521rev320augskclean 2
Generalguidanceholdtimeqas13 521rev320augskclean 2
 
generalguidanceholdtimeqas13-521rev320augskclean
generalguidanceholdtimeqas13-521rev320augskcleangeneralguidanceholdtimeqas13-521rev320augskclean
generalguidanceholdtimeqas13-521rev320augskclean
 
WHO Good Practices for Pharmaceutical Microbiology Laboratories
 WHO Good Practices for Pharmaceutical Microbiology Laboratories WHO Good Practices for Pharmaceutical Microbiology Laboratories
WHO Good Practices for Pharmaceutical Microbiology Laboratories
 
guias de amostragem.pdf
guias de amostragem.pdfguias de amostragem.pdf
guias de amostragem.pdf
 
WHO Guideline on Quality Risk Management
WHO Guideline on Quality Risk Management WHO Guideline on Quality Risk Management
WHO Guideline on Quality Risk Management
 
Carbon Footprinting and Healthcare
Carbon Footprinting and HealthcareCarbon Footprinting and Healthcare
Carbon Footprinting and Healthcare
 
PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)
 
Pe 009 13 gmp guide (x annexes)
Pe 009 13 gmp guide (x annexes)Pe 009 13 gmp guide (x annexes)
Pe 009 13 gmp guide (x annexes)
 
3-ICH-guidelines-6th-Sem.pdf
3-ICH-guidelines-6th-Sem.pdf3-ICH-guidelines-6th-Sem.pdf
3-ICH-guidelines-6th-Sem.pdf
 
NICE scientific advice between 2009 and 2015
NICE scientific advice between 2009 and 2015NICE scientific advice between 2009 and 2015
NICE scientific advice between 2009 and 2015
 
Who gmp
Who gmpWho gmp
Who gmp
 
gmp-WHO.pdf
gmp-WHO.pdfgmp-WHO.pdf
gmp-WHO.pdf
 
Yêu cầu cho thực hành tốt sản xuất thuốc (gmp who) – phần 1 (e)
Yêu cầu cho thực hành tốt sản xuất thuốc (gmp who) – phần 1 (e)Yêu cầu cho thực hành tốt sản xuất thuốc (gmp who) – phần 1 (e)
Yêu cầu cho thực hành tốt sản xuất thuốc (gmp who) – phần 1 (e)
 
Các chỉ tiêu chính trong bộ tiêu chuẩn GMP WHO
Các chỉ tiêu chính trong bộ tiêu chuẩn GMP WHOCác chỉ tiêu chính trong bộ tiêu chuẩn GMP WHO
Các chỉ tiêu chính trong bộ tiêu chuẩn GMP WHO
 
1978237935_WHOGMP_ICH.ppt
1978237935_WHOGMP_ICH.ppt1978237935_WHOGMP_ICH.ppt
1978237935_WHOGMP_ICH.ppt
 
Demo of NABH Documentation Kit for Pre Accreditation
Demo of NABH Documentation Kit for Pre AccreditationDemo of NABH Documentation Kit for Pre Accreditation
Demo of NABH Documentation Kit for Pre Accreditation
 
ICH - quality guidelines
ICH - quality guidelinesICH - quality guidelines
ICH - quality guidelines
 
Hdbs16,phụ lục 9 gmp who, kiểm soát ảnh hưởng đến môi trường của các thiết bị...
Hdbs16,phụ lục 9 gmp who, kiểm soát ảnh hưởng đến môi trường của các thiết bị...Hdbs16,phụ lục 9 gmp who, kiểm soát ảnh hưởng đến môi trường của các thiết bị...
Hdbs16,phụ lục 9 gmp who, kiểm soát ảnh hưởng đến môi trường của các thiết bị...
 
OHE Lunchtime Seminar: Health Technology Assessment Scientific and Outcomes A...
OHE Lunchtime Seminar:Health Technology Assessment Scientific and Outcomes A...OHE Lunchtime Seminar:Health Technology Assessment Scientific and Outcomes A...
OHE Lunchtime Seminar: Health Technology Assessment Scientific and Outcomes A...
 

More from Công ty Cổ phần Tư vấn Thiết kế GMP EU

Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...
Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...
Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...
Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...
Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...
QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...
QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...
QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...
QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...
QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...
QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...
QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...
QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...
QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...
QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...
QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...
QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...Công ty Cổ phần Tư vấn Thiết kế GMP EU
 

More from Công ty Cổ phần Tư vấn Thiết kế GMP EU (20)

Quyết định 878/QĐ-QLD 2023 công bố Danh mục thuốc biệt dược gốc Đợt 5
Quyết định 878/QĐ-QLD 2023 công bố Danh mục thuốc biệt dược gốc Đợt 5Quyết định 878/QĐ-QLD 2023 công bố Danh mục thuốc biệt dược gốc Đợt 5
Quyết định 878/QĐ-QLD 2023 công bố Danh mục thuốc biệt dược gốc Đợt 5
 
DANH MỤC DỰ ÁN GMP - ISO.pptx
DANH MỤC DỰ ÁN GMP - ISO.pptxDANH MỤC DỰ ÁN GMP - ISO.pptx
DANH MỤC DỰ ÁN GMP - ISO.pptx
 
ICH Q11 Combine.pdf
ICH Q11 Combine.pdfICH Q11 Combine.pdf
ICH Q11 Combine.pdf
 
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần II.pptx
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần II.pptxThực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần II.pptx
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần II.pptx
 
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần I.pptx
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần I.pptxThực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần I.pptx
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần I.pptx
 
GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I.pdf
GUIDE TO GOOD MANUFACTURING PRACTICE  FOR MEDICINAL PRODUCTS PART I.pdfGUIDE TO GOOD MANUFACTURING PRACTICE  FOR MEDICINAL PRODUCTS PART I.pdf
GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I.pdf
 
Danh sách các cơ sở trong nước đạt tiêu chuẩn nguyên tắc GLP. pdf
Danh sách các cơ sở trong nước đạt tiêu chuẩn nguyên tắc GLP. pdfDanh sách các cơ sở trong nước đạt tiêu chuẩn nguyên tắc GLP. pdf
Danh sách các cơ sở trong nước đạt tiêu chuẩn nguyên tắc GLP. pdf
 
ISPE Good manufacturing practice
ISPE Good manufacturing practiceISPE Good manufacturing practice
ISPE Good manufacturing practice
 
Hồ sơ năng lực GMP EU
Hồ sơ năng lực GMP EUHồ sơ năng lực GMP EU
Hồ sơ năng lực GMP EU
 
Prequalified Active Pharmaceutical Ingredients.pptx
Prequalified Active Pharmaceutical Ingredients.pptxPrequalified Active Pharmaceutical Ingredients.pptx
Prequalified Active Pharmaceutical Ingredients.pptx
 
Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...
Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...
Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...
 
Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...
Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...
Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...
 
QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...
QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...
QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...
 
FDA: Practices to Prevent Unsafe Contamunation of Animal Feed from Drug Carvover
FDA: Practices to Prevent Unsafe Contamunation of Animal Feed from Drug CarvoverFDA: Practices to Prevent Unsafe Contamunation of Animal Feed from Drug Carvover
FDA: Practices to Prevent Unsafe Contamunation of Animal Feed from Drug Carvover
 
FDA: Guidance-Labeling Infant Formula-March2023
FDA: Guidance-Labeling Infant Formula-March2023FDA: Guidance-Labeling Infant Formula-March2023
FDA: Guidance-Labeling Infant Formula-March2023
 
QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...
QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...
QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...
 
QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...
QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...
QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...
 
QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...
QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...
QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...
 
QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...
QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...
QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...
 
QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...
QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...
QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...
 

Recently uploaded

Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...hotbabesbook
 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...indiancallgirl4rent
 
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...narwatsonia7
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escortsaditipandeya
 
Chandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD availableChandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD availableDipal Arora
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomdiscovermytutordmt
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escortsvidya singh
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiAlinaDevecerski
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Deliverynehamumbai
 
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...Call Girls in Nagpur High Profile
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...Neha Kaur
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableNehru place Escorts
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatorenarwatsonia7
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...aartirawatdelhi
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 

Recently uploaded (20)

Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
 
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
 
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
 
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCREscort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
 
Chandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD availableChandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD available
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
 
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
 

Hướng dẫn bổ sung về quy trình sản xuất tốt hệ thống hvac cho các hình thức bào chế dược phẩm không tiệt trùng

  • 1. Draft document for comment 1 SUPPLEMENTARY GUIDELINES ON 2 GOOD MANUFACTURING PRACTICES FOR HEATING, 3 VENTILATION AND AIR-CONDITIONING SYSTEMS FOR 4 NON-STERILE PHARMACEUTICAL DOSAGE FORMS 5 (May 2016) 6 REVISED DRAFT FOR COMMENT 7 8 9 10 11 12 © World Health Organization 2016 13 All rights reserved. 14 This draft is intended for a restricted audience only, i.e. the individuals and organizations having 15 received this draft. The draft may not be reviewed, abstracted, quoted, reproduced, transmitted, 16 distributed, translated or adapted, in part or in whole, in any form or by any means outside these 17 individuals and organizations (including the organizations' concerned staff and member 18 organizations) without the permission of the World Health Organization. The draft should not be 19 displayed on any website. 20 Please send any request for permission to: 21 Dr Sabine Kopp, Group Lead, Medicines Quality Assurance, Technologies, Standards and Norms, 22 Department of Essential Medicines and Health Products, World Health Organization, CH-1211 23 Geneva 27, Switzerland. Fax: (41-22) 791 4730; email: kopps@who.int 24 25 The designations employed and the presentation of the material in this draft do not imply the 26 expression of any opinion whatsoever on the part of the World Health Organization concerning the 27 legal status of any country, territory, city or area or of its authorities, or concerning the delimitation 28 of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which 29 there may not yet befull agreement. 30 The mention of specific companies or of certain manufacturers’ products does not imply that they 31 are endorsed or recommended by the World Health Organization in preference to others of a similar 32 nature that are not mentioned. Errors and omissions excepted, the names of proprietary productsare 33 distinguished by initial capital letters. 34 All reasonable precautions have been taken by the World Health Organization to verify the 35 information contained in this draft. However, theprinted material is being distributed without 36 warranty of any kind, either expressed or implied. The responsibility for theinterpretation and use Should you have any comments on the attached text, please send these to Dr S. Kopp, Group Lead, Medicines Quality Assurance, Technologies, Standards and Norms (kopps@who.int) with a copy to Ms MarieGaspard (gaspardm@who.int) by 12 July 2016. Medicines Quality Assurance working documents will be sent out electronically only and will also be placed on the Medicines website forcomment under “Current projects”. If you do not already receive our draft working documents please let us have your email address (to bonnyw@who.int) and we will add it to our electronic mailing list.
  • 2. Working document QAS/15.639/Rev.1 page 2 37 of thematerial lies with the reader. In no event shall the World Health Organization be liable for 38 damages arising from its use. 39 This draft does not necessarily represent the decisions or the stated policy of the World Health 40 Organization.
  • 3. 41 SCHEDULE FOR THE PROPOSED ADOPTION PROCESS OF 42 DOCUMENT QAS/15.639 43 SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING 44 PRACTICES FOR HEATING, VENTILATION AND AIR- 45 CONDITIONING SYSTEMS FOR NON-STERILE 46 PHARMACEUTICAL DOSAGE FORMS. 47 PROPOSAL FOR REVISION Discussion of proposed need for revision in view of the current trends in engineering and experience gained during the implementation of this guidance in inspection during informal consultation on data management, bioequivalence, GMP and medicines’ inspection 29 June– 1 July 2015 Preparation of draft proposal for revision by Mr D. Smith, consultant to the Medicines Quality Assurance group and Prequalification Team (PQT)-Inspections, based on the feedback received during the meeting and from PQT-Inspections July–August 2015 Circulation of revised working document for public consultation September 2015 Consolidation of comments received and review of feedback 10 October 2015 Presentation to the fiftieth meeting of the WHO Expert Committee on Specifications for Pharmaceutical Preparations 12–16 October 2015 Consolidation of comments received and review of feedback January–March 2016 Discussion at the informal consultation on good practices for health products manufacture and inspection, Geneva, 4–6 April 2016 Preparation of revision by Mr D. Smith, based on comments provided by Mr A. Kupferman and Dr A.J. Van Zyl, both participants at the above-mentioned consultation. May 2016
  • 4. Working document QAS/15.639/Rev.1 page 4 Circulation of revised working document for public consultation May 2016
  • 5. Working document QAS/15.639/Rev.1 page 3 Consolidation of comments received and review of feedback August–September 2016 Presentation to the fifty-first meeting of the WHO Expert Committee on Specifications for Pharmaceutical Preparations 17–21 October 2016 Any other follow-up action as required … 48 49 50 51
  • 6. Working document QAS/15.639/Rev.1 page 4 52 BACKGROUND 53 During the consultation on data management, bioequivalence, GMP and 54 medicines’ inspection held in 2015 the possible revision of the guidance 55 for (WHO Technical Report Series, No. 961, Annex 5, 2011) was 56 discussed with the inspectors. It was suggested that in light of the new 57 developments a draft for revision be prepared. This new proposal for 58 revision was drafted based on the feedback received, the new, current 59 trends in engineering and the experience gained during the implementation 60 of this guidance in inspection. 61 At the same time, the opportunity was used to improve the graphic images 62 and make them more readable in e-version as well as in print. 63 Summary of main changes 64 Below is a list of the main changes that have been made to the WHO Technical 65 Report Series, No. 961, 2011, Annex 5: Supplementary guidelines on good 66 manufacturing practices for heating, ventilation and air-conditioning systems for 67 non-sterile pharmaceutical dosage forms. 68 69 1. The Premises section has been moved towards the beginning of the document 70 due to its important impact on HVAC designs. In addition the text has been 71 expanded and a number of sample layouts have been included. 72 73 2. The HVAC sections have been re-arranged into a more logical sequence. 74 75 3. The Commissioning, Qualification and Validation (C, Q & V) section has 76 been aligned with the proposed revisions to the Supplementary GMP 77 Validation TRS, No. 937, Annex 4 guidelines. 78 79 4. Significant notes were added under the new Supplementary notes on test 80 procedures section. 81 82 5. The Maintenance section has been separated out of the C, Q & V section. 83 84 6. All the diagrams have been revised (mainly to achieve better clarity). 85 86 7. Throughout the document additional notes have been added and text revised 87 to provide better understanding and avoid ambiguity. 88 89
  • 7. Working document QAS/15.639/Rev.1 page 5 90 91 92 93 1. Introduction 94 2. Scope of document 95 3. Glossary 96 4. Premises Contents page 97 5. Design of HVAC systems and components 98 5.1 General 99 5.2 Air distribution 100 5.3 Recirculation system 101 5.4 Full fresh-air systems 102 5.5 Additional system components 103 6. Protection 104 6.1 Products and personnel 105 6.2 Air filtration and air patterns 106 6.3 Unidirectional airflow 107 6.4 Infiltration 108 6.5 Cross-contamination and contamination 109 6.6 Pressure differential concept (high pressure differential, 110 low airflow) 111 6.7 Physical barrier concept 112 6.8 Temperature and relative humidity 113 7. Dust control 114 8. Protection of the environment 115 8.1 General 116 8.2 Dust in exhaust air 117 8.3 Vapour and fume removal 118 9. Commissioning, qualification and validation 119 9.1 General 120 9.2 Commissioning 121 9.3 Qualification 122 9.4 Supplementary notes on test procedures 123 9.4.1 General 124 9.4.2 Airflow measurements 125 9.4.3 Non-variable air particle counts 126 9.4.4 HEPA filter integrity tests 127 10. Maintenance 128 References 129 Further reading 130130
  • 8. Working document QAS/15.639/Rev.1 page 6 1311 3 1 1321 3 2 1331 3 3 1341 3 4 1351 3 5 1361 3 6 1371 3 7 1381 3 8 1391 3 9 1401 4 0 1411 4 1 1421 4 2 1431 4 3 1441 4 4 1451 4 5 1461 4 6 1471 4 7 148148 149149 150150 151151 152152 153153 154154 155155 156156 157157 158158 159159 160160 161161 162162 163163 164164 165165 166166 167167 168168 169169 170170 171171 172172 173173 174174
  • 9. Working document QAS/15.639/Rev.1 page 7 1. I N T R O D U C T I O N H e a t i n g , v e n t i l a t i o n a n d a i r - c o nditioning (HVAC) play an important role in ensuring the manufacture of quality pharmaceutical products. A well designed HVAC system will also provide comfortable conditions for operators. These guidelines mainly focus on recommendations for systems for manufacturers of non-sterile dosage forms, and include tablets, capsules, powders, liquids, creams, ointments, etc. The HVAC design principles contained in the guidelines may be applied to other dosage forms. HVAC system design influences architectural layouts with regard to items such as airlock positions, doorways and lobbies. The architectural components have an effect on room pressure, differential cascades and cross- contamination control. The prevention of contamination and cross- contamination is an essential design consideration of the HVAC system. In view of these critical aspects, the design of the HVAC system should be considered at the concept design stage of a pharmaceutical manufacturing plant. Temperature, relative humidity and ventilation should be appropriate and should not adversely affect the quality of pharmaceutical products during their manufacture and storage, or the accurate functioning of equipment. This document aims to give guidance to pharmaceutical manufacturers and inspectors of pharmaceutical manufacturing facilities on the design, installation, qualification and maintenance of the HVAC systems. These guidelines are intended to complement those provided in Good manufacturing practices for pharmaceutical products (1) and should be read in conjunction with the parent guide. The additional standards addressed by this guide should, therefore, be considered supplementary to the general requirements set out in the main principles guide (WHO Technical Report Series, No. 961, Annex 3) 2. SCOPE OF DOCUMENT These guidelines focus primarily on the design and good manufacturing practices (GMP) requirements for HVAC systems for facilities for the manufacture of solid dosage forms. Most of the system design principles for facilities manufacturing solid dosage forms also apply to facilities manufacturing other dosage forms (such as liquids, cream, ointments) and other classes of products including biological products, herbal medicines, complementary medicines and finishing process steps for APIs. Non-sterile forms typically include:
  • 10. Working document QAS/15.639/Rev.1 page 8 1751 7 5 1761 7 6 1771 7 7 1781 7 8 1791 7 9 1801 8 0 1811 8 1 1821 8 2 1831 8 3 1841 8 4 1851 8 5 1861 8 6 1871 8 7 1881 8 8 1891 8 9 1901 9 0 191191 192192 193193 194194 195195 196196 197197 198198 199199 200200 201201 202202 203203 204204 205205 206206 207207 208208 209209 210210 211211 212212 213213 214214
  • 11. Working document QAS/15.639/Rev.1 page 9  p r o d u c t s w i t h l o w w a t e r a c t i v i t y ( l e s s s u b j e c t to microbial contamination), e.g. oral solid dosage forms, suppositories;  products with high water activity (more subject to microbial contamination, depending on the formulation), e.g. liquids, drops, syrups, ointments and creams. Additional specific requirements apply for air-handling systems of pharmaceutical sterile products and hazardous products. Guidelines for hazardous, sterile and biological product facilities are covered in separate WHO guidelines (WHO Technical Report Series, No. 957, Annex 3; WHO Technical Report Series, No. 961, Annex 6; and working document WHO/BS/2015.2253, intended to replace WHO Technical Report Series, No. 822, Annex 1, 1992, respectively). These guidelines are not intended to be prescriptive in specifying requirements and design parameters. There are many parameters affecting a clean area condition and it is, therefore, difficult to lay down the specific requirements for one particular parameter in isolation. Many pharmaceutical manufacturers have their own engineering design and qualification standards, and requirements may vary from one manufacturer to the next. Design parameters and user requirements should, therefore, be set realistically for each project, with a view to creating a cost-effective design, yet still complying with all regulatory standards and ensuring that product quality and safety are not compromised. The three primary aspects addressed in this guideline are the roles that the HVAC system plays in product protection, personnel protection and environmental protection (Figure 1). Cognizance should be taken of the products to be manufactured when establishing system design parameters. A facility manufacturing multiple different products may have more stringent design parameters with respect to cross-contamination control, compared with a single product facility. Risk assessment studies should be an integral part of the facility design and implementation, from the user requirement specification stage right through to validation, as indicated in the diagram below (Figure 2). Validation protocols and criteria should be justified by links to a written risk assessment.
  • 12. Working document QAS/15.639/Rev.1 page 10 Avoid Effluent Discharge Avoid Fume Discharge Prevent Contact with Fumes Protect from Product Contamination Avoid Dust Discharge Prevent Contact with Dust Contamination (Product & Staff) PROTECTION OF EXTERNAL ENVIRONMENT PERSONNEL PROTECTION PRODUCT PROTECTION GMP MANUFACTURING ENVIRONMENT Correct Temperature & Humidity 215 Figure 1. The guidelines address the various system criteria according to 216 the sequence set out in this diagram 217217 218218 219219 SYSTEMS Acceptable Comfort Conditions SYSTEM VALIDATION `
  • 13. Working document QAS/15.639/Rev.1 page 11 2202 2 0 2212 2 1 Figure 2. GMP compliance sequence diagram 222222 223223 224224 PROJECT INCEPTION USER REQUIREMENT SPECIFICATION QUALIFICATION & VALIDATION FACILITY LAYOUTS R RI IS SK K A AS SS SE ES SS SM ME EN NT T S ST TU UD DI IE ES S Installations & Commissioning V C & ES E ENERGY EFFICIENCY STUDIES
  • 14. Working document QAS/15.639/Rev.1 page 12 2252 2 5 2262 2 6 2272 2 7 2282 2 8 2292 2 9 2302 3 0 2312 3 1 2322 3 2 2332 3 3 2342 3 4 2352 3 5 2362 3 6 2372 3 7 2382 3 8 2392 3 9 2402 4 0 2412 41 242242 243243 244244 245245 246246 247247 248248 249249 250250 251251 252252 253253 254254 255255 256256 257257 258258 259259 260260 261261 262262 263263 264264 265265 266266 267267 268268 269269
  • 15. Working document QAS/15.639/Rev.1 page 13 3. G L O S S A R Y T h e d e fi n i t i o n s g i v e n b e l o w a p p l y t o terms used in these guidelines. Theymay have different meanings in other contexts. acceptance criteria. Measurable terms under which a test result will be considered acceptable. action limit. The action limit is reached when the acceptance criteria of a critical parameter have been exceeded. Results outside these limits will require specified action and investigation. air changes per hour. The volume of air supplied to a room, in m3/hr, divided by the room volume, in m3. air-handling unit. The air-handling unit serves to condition the air and provide the required air movement within a facility. airflow protection booth. A booth or chamber, typically for purposes of carrying out sampling or weighing, in order to provide product containment and operator protection. airlock. An enclosed space with two or more doors, which is interposed between two or more rooms, e.g. of differing classes of cleanliness, for the purpose of controlling the airflow between those rooms when they need to be entered. An airlock is designed for and used by either people or goods (personnel airlock (PAL); material airlock (MAL)). alert limit. The alert limit is reached when the normal operating range of a critical parameter has been exceeded, indicating that corrective measures may need to be taken to prevent the action limit being reached. as-built. Condition where the installation is complete with all services connected and functioning but with no production equipment, materials or personnel present. at-rest. Condition where the installation is complete with equipment installed and operating in a manner agreed upon by the customer and supplier, but with no personnel present. central air-conditioning unit (see air-handling unit) change control. A formal system by which qualified representatives of appropriate disciplines review proposed or actual changes that might affect a validated status. The intent is to determine the need for action that
  • 16. Working document QAS/15.639/Rev.1 page 14 2702 7 0 2712 7 1 2722 7 2 2732 7 3 2742 7 4 2752 7 5 2762 7 6 2772 7 7 2782 7 8 2792 7 9 2802 8 0 2812 8 1 2822 8 2 2832 8 3 2842 8 4 2852 8 5 286286 287287 288288 289289 290290 291291 292292 293293 294294 295295 296296 297297 298298 299299 300300 301301 302302 303303 304304 305305 306306 307307 308308 309309 310310 311311 312312 313313
  • 17. Working document QAS/15.639/Rev.1 page 15 wo uld ens ure that the sys tem is mai ntai ned in a vali dat ed stat e. c l e a n a r e a ( c l e a n r o o m ) . A n area (or room or zone) with defined environmental control of particulate and microbial contamination, constructed and used in such a way as to reduce the introduction, generation and retention of contaminants within the area. clean-up (see recovery) closed system. A system where the product or material is not exposed to the manufacturing environment. commissioning. Commissioning is the documented process of verifying that the equipment and systems are installed according to specifications, placing the equipment into active service and verifying its proper action. Commissioning takes place at the conclusion of project construction but prior to validation. containment. A process or device to contain product, dust or contaminants in one zone, preventing it from escaping to another zone. contamination. The undesired introduction of impurities of a chemical or microbial nature, or of foreign matter, into or on to a starting material or intermediate, during production, sampling, packaging or repackaging, storage or transport. controlled area (classified area). An area within the facility in which specific environmental parameters, conditions and procedures are defined, controlled and monitored to prevent degradation or cross- contamination of the product. controlled not classified. An area where some environmental conditions are controlled (such as temperature), but the area has no cleanroom classification. critical parameter or component. A processing parameter (such as temperature or relative humidity) that affects the quality of a product, or a component that may have a direct impact on the quality of the product. critical quality attribute. A physical, chemical, biological or microbiological property or characteristic that should be within an appropriate limit, range or distribution to ensure the desired product quality. cross-contamination. Contamination of a starting material, intermediate product or finished product with another starting material or
  • 18. Working document QAS/15.639/Rev.1 page 16 314 product during production. 315315 316 cross-over-bench. Cross-over or step-over bench in change room to 317 demarcate the barrier between different garment change procedures. 318318 319 design condition. Design condition relates to the specified range or 320 accuracy of a controlled variable used by the designer as a basis for 321 determining the performance requirements of an engineered system. 322322 323 design qualification. Design qualification is the documented check 324 of planning documents and technical specifications for design conformity 325 with the process, manufacturing, good manufacturing practices and 326 regulatory requirements. 327327 328 differential pressure. The difference in pressure between two 329 points such as the pressure difference between an enclosed space and an 330 independent reference point, or the pressure difference between two 331 enclosed spaces. 332332 333 direct impact system. A system that is expected to have a direct 334 impact on product quality. These systems are designed and commissioned 335 in line with good engineering practice and, in addition, are subject to 336 qualification practices. 337337 338 exfiltration. Exfiltration is the egress of air from a controlled area to 339 an external zone. 340 341 extract air. Air leaving a space, which could be either return air or 342 exhaust air. Return air means that the air is returned to the air-handling unit 343 and exhaust air means that the air is vented to atmosphere. 344 345 facility. The built environment within which the clean area installation 346 and associated controlled environments operate together with their supporting 347 infrastructure. 348348 349 good engineering practice. Established engineering methods and 350 standards that are applied throughout the project life cycle to deliver 351 appropriate, cost-effective solutions. 352352 353 hazardous substance or product. A product or substance that may 354 present a substantial risk of injury to health or to the environment. 355355 356 HEPA filter. High efficiency particulate air filter. 357357
  • 19. Working document QAS/15.639/Rev.1 page 17 358 HVAC. Heating, ventilation and air-conditioning. Also referred to 359 as Environmental control systems. 360360 361 indirect impact system. This is a system that is not expected to 362 have a direct impact on product quality, but typically will support a direct 363 impact system. These systems are designed and commissioned according to 364 good engineering practice only. 365365 366 infiltration. Infiltration is the ingress of air from an external zone 367 into a controlled area. 368 369 installation qualification. Installation qualification is documented 370 verification that the premises, HVAC system, supporting utilities and 371 equipment have been built and installed in compliance with their approved 372 design specification. 373 374 ISO 14644. The International Standards Organization has developed 375 a set of standards for the classification and testing of cleanrooms. The 376 standard comprises 12 separate parts. Where ISO 14644 is referenced it 377 implies the latest revision. 378378 379 NLT. Not less than. 380380 381 NMT. Not more than. 382382 383 no-impact system. This is a system that will not have any impact, 384 either directly or indirectly, on product quality. These systems are designed 385 and commissioned according to good engineering practice only. 386386 387 non-critical parameter or component. A processing parameter or 388 component within a system where the operation, contact, data control, alarm 389 or failure will have an indirect impact or no impact on the quality of the 390 product. 391391 392 normal operating range. The range that the manufacturer selects as 393 the acceptable values for a parameter during normal operations. This range 394 must be within the operating range. 395395 396 OOS. Out of specification. In relation to HVAC systems this could 397 refer to any of the environmental conditions being OOS,i.e. falling outside of 398 alert or action limits. 399399 400 operating limits. The minimum and/or maximum values that will 401 ensure that product and safety requirements are met.
  • 20. Working document QAS/15.639/Rev.1 page 18 4024 0 2 4034 0 3 4044 0 4 4054 0 5 4064 0 6 4074 0 7 4084 0 8 4094 0 9 4104 1 0 4114 1 1 4124 1 2 4134 1 3 4144 1 4 4154 1 5 4164 1 6 4174 1 7 4184 18 419419 420420 421421 422422 423423 424424 425425 426426 427427 428428 429429 430430 431431 432432 433433 434434 435435 436436 437437 438438 439439 440440 441441 442442 443443 444444 445445 446446
  • 21. Working document QAS/15.639/Rev.1 page 19 o p e r a t i n g r a n g e . O p e r a t i n g r a n g e i s t h e r a n g e of validated critical parameters within which acceptable products can be manufactured. operational condition. This condition relates to carrying out room classification tests with the normal production process with equipment in operation and the normal staff present in the specific room. operational qualification. Operational qualification is the documentary evidence to verify that the equipment operates in accordance with its design specifications in its normal operating range and performs as intended throughout all anticipated operating ranges. oral solid dosage. Usually refers to an oral solid dosage plant that manufactures medicinal products such as tablets, capsules and powders to be taken orally. pass-through-hatch or pass box. A cabinet with two or more doors for passing equipment, material or product, whilst maintaining the pressure cascade and segregation between two controlled zones. A passive pass- through-hatch (PTH) has no air supply or extract. A dynamic PTH has an air supply into the chamber. performance qualification. Performance qualification is the documented verification that the process and/or the total process related to the system performs as intended throughout all anticipated operating ranges. point extraction. Air extraction to remove dust with the extraction point located as close as possible to the source of the dust. pressure cascade. A process whereby air flows from one area, which is maintained at a higher pressure, to another area maintained at a lower pressure. qualification. Qualification is the planning, carrying out and recording of tests on equipment and a system, which forms part of the validated process, to demonstrate that it will perform as intended. quality critical process parameter. A process parameter which could have an impact on the critical quality attribute. recovery. Room recovery or clean-up tests are performed to determine whether the installation is capable of returning to a specified cleanliness level within a finite time, after being exposed briefly to a source of airborne particulate challenge.
  • 22. Working document QAS/15.639/Rev.1 page 20 447447 448 relative humidity. The ratio of the actual water vapour pressure of 449 the air to the saturated water vapour pressure of the air at the same 450 temperature expressed as a percentage. More simply put, it is the ratio 451 of the mass of moisture in the air, relative to the mass at 100% moisture 452 saturation, at a given temperature. 453453 454 standard operating procedure. An authorized written procedure, 455 giving instructions for performing operations, not necessarily specific to a 456 given product or material, but of a more general nature (e.g. operation of 457 equipment, maintenance and cleaning, validation, cleaning of premises and 458 environmental control, sampling and inspection). Certain standard operating 459 procedures may be used to supplement product-specific master and batch 460 production documentation. 461461 462 turbulent flow. Turbulent flow, or non-unidirectional airflow, is air 463 distribution that is introduced into the controlled space and then mixes with 464 room air by means of induction. 465465 466 unidirectional airflow. Unidirectional airflow is a rectified airflow 467 over the entire cross-sectional area of a clean zone with a steady velocity 468 and approximately parallel streamlines (see also turbulent flow). (Modern 469 standards no longer refer to laminar flow, but have adopted the term 470 unidirectional airflow.) 471471 472 validation. The documented act of proving that any procedure, 473 process, equipment, material, activity or system actually leads to the 474 expected results. 475475 476 validation master plan. Validation master plan is a high-level 477 document which establishes an umbrella validation plan for the entire 478 project and is used as guidance by the project team for resource and 479 technical planning (also referred to as master qualification plan). 480480 481481 482 4. PREMISES 483483 484 4.1. There is a close relationship between architectural design and 485 HVAC design, as they both have an impact on the functionality of the 486 other. HVAC system design influences architectural layouts with regard to 487 items such as airlock positions, doorways and lobbies. The architectural 488 layouts and building components have an effect on room pressure 489 differential cascades and cross-contamination control. The prevention of 490 contamination and cross-contamination is an essential design consideration
  • 23. Working document QAS/15.639/Rev.1 page 21 491 of the HVAC system. In view of these critical aspects, the design of the 492 HVAC system should be considered at the concept design stage of a 493 pharmaceutical manufacturing plant, and the design should be closely 494 coordinated with the architectural designers. The above design 495 considerations should also be applicable to facility upgrades or the 496 retrofitting of facilities. 497497 498 4.2. As the efficient operation of the air-handling system and cleanliness 499 levels attained are reliant on the correct building layout and building 500 finishes, the following items should be considered. 501501 502 4.2.1. Adequate airlocks, such as personnel airlocks (PAL) and/or material 503 airlocks (MAL), pass-through hatches (PTH), change rooms and passages 504 should be provided to limit air transfer between different cleanliness zones, 505 and may be provided to limit cross-contamination within the same 506 cleanliness zone. These should have supply and extract air systems as 507 appropriate. 508508 509 4.2.2. Areas such as airlocks, change rooms and passages should be 510 designed so that the required pressure cascades can be achieved. 511511 512 4.2.3. Detailed diagrams depicting pressure cascades, air flow directions 513 and flow routes for personnel and materials should be prepared and 514 maintained. 515515 516 4.2.4. Where possible, personnel and materials should not move from a 517 higher cleanliness zone to a lower cleanliness zone and back to a higher 518 cleanliness zone (if moving from a lower cleanliness zone to a higher 519 cleanliness zone, changing/decontamination procedures should be 520 followed). 521521 522 4.2.5. The final change room should be the same good manufacturing 523 practices (GMP) classification grade (at rest) as the area into which it leads. 524524 525 4.2.6. Door gaps around the door perimeter have a marked impact on the 526 pressure differential across the doorway. The fit of the doors should be 527 agreed upon between the architect and the HVAC designer to ensure that 528 the correct leakages are allowed for. Likewise the maintenance of doors is 529 a critical factor in room pressure control (a poorly fitting door can severely 530 compromise a room pressure differential). 531531
  • 24. Working document QAS/15.639/Rev.1 page 22 532 4.2.7. Where the opening and closing of airlock doors could lead to cross- 533 contamination, these airlock doors should not be opened simultaneously. 534 An interlocking system and/or a visual and/or audible warning system 535 should be operated to prevent the opening of more than one door at a time. 536536 537 4.2.8. Doors should be carefully designed to avoid un-cleanable recesses. 538 Swing doors should open to the high-pressure side and be provided with 539 self-closers. Exceptions are permitted based on site environmental, fire, 540 health and safety containment requirements. Cognizance should be taken of 541 possible room pressure changes due to fan failure and the impact on ease of 542 opening doors for escape purposes. 543543 544 4.2.9. The choice of building finishes and materials also has an impact on 545 air conditioning performance and air cleanliness. Materials should be 546 selected that will provide a well-sealed building to facilitate room pressure 547 control. Materials and paint finishes should also be non-dust and particle 548 liberating as this impacts on room cleanliness. Finishes should be easy to 549 clean and non-absorbent. To reduce the accumulation of dust and to 550 facilitate cleaning, there should be no uncleanable recesses and a minimum 551 of projecting ledges, shelves, cupboards and equipment. 552552 553 The following diagrams are examples of room and suite layouts with their 554 associated room pressures. These are purely examples and other factors 555 may dictate different room arrangements and room pressures. 556 Room pressure differentials could be lower or higher depending on the 557 specific design and operations. The purpose of a pressure differential is to 558 enhance the separation between areas with different levels of cleanliness 559 and also to provide containment to prevent cross-contamination. Where 560 there is no difference in cleanliness level, and no potential for cross 561 contamination, a zero pressure differential can be applied. 562562
  • 25. Working document QAS/15.639/Rev.1 page 23 5635 6 3 5645 6 4 5655 6 5 5665 6 6 5675 6 7 5685 6 8 5695 69
  • 26. Working document QAS/15.639/Rev.1 page 24 35 Pa Staff Airlock BIN BIN 25 Pa COB BIN Floor Scale 35 Pa Change Room Pallet BIN BIN Flow 25 Pa BIN BIN Airf low Protection Plenum Wash Bay 25 Pa DispensaryPre-Staging Room 15 Pa DispensaryPost-Staging Perf orated Worktop Table Scale Weigh Booth Fig ure 3. Ex am ple of a wei gh boo th lay out N o t e : S i milar air handling and product protection principles apply to sampling suites. Return Air Shaft Staff Flow Material Flow Material Flow Room
  • 27. Working document QAS/15.639/Rev.1 page 25 COB 570 Figure 4. Example of a dispensary suite Production Passage Dispensary Post-Staging Room Staff Flow Wash Bay Optional location MAL Change Room MAL Change Room Weigh Booth 1 Airf low Protection Plenum Weigh Booth 2 Airf low Protection Plenum Broken Bulk Store MAL Wash Bay Optional location MAL Wash Bay Optional location Dispensary Pre-Staging Room Material Flow 5715 7 1 5725 7 2 Notes: Staff Flow Material Flow MAL W/h Staff 573 1. Two alternative locations are indicated for the wash bays. 574 2. The broken bulk store is optional. Alternatively partially used 575 containers can be returned to the warehouse. 576 3. The inclusion of MALs at entrance and exit to weigh booths depend on 577 containment risks and the pressure cascade design. Return Air Shaft Return Air Shaft Material Flow Material Flow S ta ff Flow S ta ff Flow S ta ff Flow S ta ff Flow Material Flow Material Flow Material Flow S ta ff Flow S ta ff Flow S ta ff Flow S ta ff Flow Warehouse Area
  • 29. Working document QAS/15.639/Rev.1 page 27 15 Pa Female Toilets -10 Pa Lobby 0 Pa COB 15 Pa -10 Pa Male Toilets COB Production Passage Female Change Room Male Change Room Un-classified Zone 5805 8 0 5815 8 1 5825 8 2 Figure 5. Change rooms and washing area layouts 30 Pa
  • 30. Working document QAS/15.639/Rev.1 page 28 583 Figure 6. Example of a compression cubicle with change room and MAL, 584 for higher risk materials. 585585 586 Note: The inclusion of the PAL and MAL is dependent on product risk, 587 range of products handled in adjacent cubicles, pressure cascade and open 588 vs closed manufacturing processes. 589589 590590 Change Room 25 Pa Supply Air Grille 35 Pa 15 Pa MAL 25 Pa COB Production Passage Compression Cubicle
  • 31. Working document QAS/15.639/Rev.1 page 29 Supply Air Grille 30 Pa 15 Pa Compression Cubicle 591 Figure 7. Example of compression cubicle without change room and MAL, 592 for lower risk materials (inclusion of airlocks dependant on risk assessment) 593593 594 Note the supply air from the ceiling towards the front of the cubicle and air 595 extract at low level at the back corners of the cubicle. 596596 Production Passage
  • 32. Working document QAS/15.639/Rev.1 page 30 5975 9 7 5985 9 8 5995 9 9 6006 0 0 6016 0 1 6026 0 2 6036 0 3 6046 0 4 6056 0 5 606606 607607 608608 609609 610610 611611 612612 613613 614614 615615 616616
  • 33. Working document QAS/15.639/Rev.1 page 31 Material Flow Material Flow Wash Bay 25 Pa Material Flow Material Flow Equipment Drying 45 Pa 35 Pa Fig ure 8. Ex am ple of wa sh- bay suit e 5. D E S I G N O F H V A C SYSTEMS AND COMPONENTS 5.1. General 5.1.1. The required degree of air cleanliness in most non-sterile dosage form manufacturing facilities can normally be achieved without the use of high-efficiency particulate air (HEPA) filters, provided the air is not recirculated or in the case of a single-product facility. Many open product zones of non-sterile dosage form facilities are capable of meeting ISO 14644-1 Class 8 or Grade D, “at-rest” condition, measured against particle sizes of 0.5 µm and 5 µm, but cleanliness may not necessarily be classified as such by manufacturers. Grade D conditions usually have a maximum viable particle concentration of 200 cfu/m3 . Alternative microbiological levels as per the table below could be used depending on risk assessments. 15 Pa 30 Pa Material Flow Production Passage Dirty Equipment Store Clean Equipment Store
  • 34. Working document QAS/15.639/Rev.1 page 32 6176 1 7 6186 1 8 6196 1 9 6206 2 0 6216 2 1 6226 2 2 6236 2 3 6246 2 4 6256 2 5 6266 2 6 6276 2 7 6286 2 8 6296 29 630630 631631 632632 633633 634634 635635 636636 637637 638638 639639 640640 641641 642642 643643 644644 645645 646646 647647 648648
  • 35. Working document QAS/15.639/Rev.1 page 33 T a b l e 1 . M i c r o b i o l o g i c a l a i r q u a l i t y i n p r oduction premises for the manufacture ofnon-sterile medicinal products Area Limits in operation Limits at rest Routine monitoring frequency of testing Manufacture of nonsterile, semi-solid4 and liquid dosage forms2 Alert limit (cfu1 /m3) Action limit (cfu/m3) (cfu/m3) 250 500 100 Weekly Manufacture of tablets, capsules and coated tablets3 500 800 400 Monthly 1 Colony-formingunit. 2 In analogy toWHO GMP guidelines, this area can alsobe classifiedas grade E. 3 In analogy toWHO GMP guidelines, this area canalso be classifiedas grade F. 4 Dependingon the product properties it maybe necessarytodefinestricter limits for water-basedsemi-solid dosage. 5.1.2. A risk assessment should be carried out to determine the room cleanliness conditions required and the extent of validation required. Once room cleanliness and environmental conditions have been determined, qualification of these conditions should be carried out. 5.1.3. There are two basic concepts of air delivery to pharmaceutical production facilities: a recirculation system; and a full fresh air system (100% outside air supply). For recirculation systems the amount of fresh air should not be determined arbitrarily on a percentage basis but, for example, by the following criteria:  sufficient fresh air to compensate for leakage from the facility and loss through exhaust air systems;  sufficient fresh air to comply with national building regulations (depends on occupant density);  sufficient fresh air for odour control;  sufficient fresh air to provide the required building pressurization. 5.1.4. Where automated monitoring systems are used, these should be capable of indicating any out-of-specification (OOS) condition by means of an alarm or similar system. Sophisticated computer-based data monitoring systems may be installed, which can aide with planning of preventive maintenance and can also provide trend logging.
  • 36. Working document QAS/15.639/Rev.1 page 34 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 (This type of system is commonly referred to as a building management system (BMS), building automation system (BAS) or system control and data acquisition (SCADA) system. If these systems are used for critical decision-making, they should be validated. If the BMS is not validated in full (or in part for these critical parameters), an independent validated environmental monitoring system (EMS) should be provided, specifically for recording and alarming critical parameters. The EMS for monitoring of critical parameters could be a computerized system or a more manual means of recording data. Critical parameters could include, for example, room temperature in production areas, humidity, differential pressures, fan failure alarms, etc.) 5.1.5. Failure of a supply air fan, return air fan, exhaust air fan or dust extract system fan can cause a system imbalance, resulting in a pressure cascade malfunction with a resultant airflow reversal. 5.1.6. Appropriate alarm systems should be in place to alert personnel if a critical fan fails. Critical alarms should be easily identifiable and visible and/or audible to relevant personnel. There should be an action plan for such alarms i.e. stop production, close up open product, move product, etc., and may include corrective and preventive action (CAPA). 5.1.7. Based on a risk assessment a fan interlock failure matrix should be set up, such that if a fan serving a high pressure zone fails, then any fans serving surrounding lower pressure areas should automatically stop, to prevent an airflow reversal and possible cross-contamination. This fan stop- start matrix should apply to the switching on and switching off of systems to ensure that there is no flow reversal causing cross-contamination. The effect of fan failure on building and HVAC components should also be assessed. A failure of one fan could cause excessive positive or negative pressures resulting in damage such as structural failure of components. 5.1.8. Materials for components of an HVAC system should be selected with care so that they do not become a source of contamination. Any component with the potential for liberating particulate or microbial contamination into the airstream should be located upstream of the final filters. 5.1.9. Where possible ventilation dampers, filters and other services should be designed and positioned so that they are accessible from outside the manufacturing areas (service voids or service corridors) for maintenance purposes.
  • 37. Working document QAS/15.639/Rev.1 page 35 R Room with ceiling return air S R ROOM 2 AIR HANDLING UNIT - S = Supply Air R = Return Air F = Fresh Air F R S S + R + S Room with low level return air R R ROOM 1 R 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 5.2. Air distribution 5.2.1. The positioning of supply and extract grilles should be such as to provide effective room flushing. Low-level return or exhaust air grilles are usually preferred. However, where this is not possible, a higher air change rate may be needed to achieve a specified clean area condition, e.g. where ceiling return air grilles are used. 5.2.2. There may be alternative locations for return air leaving the room. For example, referring to Figure 9, room 1 (low-level return air) and room 2 (ceiling return air). Figure 9. Air-handling system with high-efficiency particulate air filters in air-handling unit 708 709 710 The airflow schematics of the two systems (Figures 9 and 10 ) indicate 711 air-handling units with return air or recirculated air, having a percentage 712 of fresh air added. Depending on product characteristics and dust loading 713 it is sometimes preferable to fit filters on return air outlets or in return air 714 ducting. 715 716 Primary Filter Cooling Coil Supply Air Fan Secondary Filter HEPA Filter
  • 38. Working document QAS/15.639/Rev.1 page 36 AIR HANDLING UNIT - S = Supply Air R = Return Air F = Fresh Air F S R S R + + + S S R HEPA Filters S S Room with low level return air S R S Room with Horizontal UDAF Room with Vertical UDAF R R R ROOM 4 ROOM 5 ROOM 3 717 718 719 720 721 722 723 724 725 726 727 728 729 Figure 10 is a schematic diagram of an air-handling system serving rooms with horizontal unidirectional flow, vertical unidirectional flow and turbulent flow, for rooms 3, 4 and 5, respectively. In this case the HEPA filters are terminally mounted at the rooms and not in the AHU. Terminally mounted supply air HEPA filters can assist with preventing cross- contamination from room to room in the event of a fan failure condition. The decision whether to install terminal HEPA filters should be based on a risk-assessment study. Figure 10. Horizontal unidirectional flow, vertical unidirectional flow and turbulent flow 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 5.3. Recirculation system 5.3.1. The risk of contamination and/ or cross-contamination (including by fumes and volatiles) due to recirculation of air should be evaluated to determine if recirculation of air is acceptable. 5.3.2. Depending on the airborne contaminants in the return-air system it may be acceptable to use recirculated air, provided that HEPA filters are installed in the supply air stream (or return air stream) to remove contaminants and thus prevent cross-contamination. The HEPA filters for this application should have an EN 1822 classification of H13. 5.3.3. HEPA filters may not be required where the air-handling system is serving a single product facility and there is evidence that cross- contamination would not be possible. 5.3.4. Recirculation of air in areas where pharmaceutical dust is not HEPA Filters Primary Filter Cooling Coil Supply Air Fan Sec o n d a r y Filter
  • 39. Working document QAS/15.639/Rev.1 page 37 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 generated such as secondary packing, may not require HEPA filters in the system. 5.3.5. HEPA filters may be located in the air-handling unit or placed terminally. Where HEPA filters are t erminall y mounted t hey should preferably not be connected to the ducting by means of flexible ducting. Due to the high air pressure required for the terminal filter, this connection should preferably be a rigid duct connection. Where flexible ducting is used, it should be as short as possible and properly fixed to withstand duct pressure. When HEPA filters are terminally mounted, it should be possible to carry out filter integrity tests from within the room. The filter housings will therefore require ports for measuring appropriate upstream concentration (refer to ISO 14644.3) and penetration concentration from within the room. In addition it should be possible to measure the filter pressure drop in individual HEPA filters by means of test ports provided. 5.3.6. Air containing solvents or flammable vapours should not be recirculated to the HVAC system. Air containing dust from highly toxic processes should only be recirculated if risk assessments shows adequate protection and special precautions are in place (e.g. triple HEPA filtration). 5.4. Full fresh-air systems 5.4.1. The required degree of filtration of the exhaust air depends on the exhaust air contaminants and local environmental regulations. HEPA filters in the exhaust system would normally only be required when handling hazardous materials. Figure 11 indicates a system operating on 100% fresh air and would normally be used in a facility dealing with toxic products or solvents, where recirculation of air with contaminants should be avoided.
  • 40. Working document QAS/15.639/Rev.1 page 38 AIR HANDLING UNIT - S = Supply Air R = Return Air F = Fresh Air E = Exhaust Air F Fresh Air S + S PRODUCTION FACILITY EXHAUST AIR HANDLING UNIT E E E Exhaust Air Degree of filtration required depends on exhaust air contaminants 785 786 787 Figure 11. Full fresh-air system 788 789 790 791 792 793 794 795 796 797 798 799 800 Note: A HEPA filter on supply air is optional for a full fresh-air system. A HEPA filter on the exhaust air is dependent on type of contaminants in the exhaust leaving the room. 5.4.2. Energy-recovery wheels if used in multiproduct facilities should have been subjected to a risk assessment to determine if there is any risk of cross-contamination. When such wheels are used they should not become a source of possible contamination (see Figure 12). Note: Alternatives to the energy-recovery wheels, such as crossover plate heat exchangers and water-coil heat exchangers, may be used in multiproduct facilities. Primary Filter Cooling Coil Exhaust Air Fan Supply Air Fan HEPA Filter Secondary Filter Secondary Filter Primary Filter HEPA Filter
  • 41. Working document QAS/15.639/Rev.1 page 39 801 802 Figure 12. Full fresh-air system with energy recovery 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 5.4.3. The potential for air leakage between the supply air and exhaust air as it passes through the wheel should be prevented. The relative pressures between supply and exhaust air systems should be such that the exhaust air system operates at a lower pressure than the supply system. 5.5. Additional system components 5.5.1. A schematic diagram of the airflow for a typical system serving a low relative humidity suite is represented in Figure 13. Air can be dried with a chemical drier (e.g. a rotating desiccant wheel which is continuously regenerated by means of passing hot air through one segment of the wheel). Alternative methods of drying air are also available. AIR HANDLING UNIT S = Supply Air R = Return Air F = Fresh Air E = Exhaust Air F + S Energy Recovery Wheel PRODUCTION FACILITY E Exhaust Air EXHAUST AIR FILTER UNIT E E Degree of filtration required depends on exhaust air contaminants - Primary Filter Exhaust Air Fan Fresh Air Cooling Coil HEPA Filter Supply Air Fan Secondary Filter Primary Filter Secondary Filter HEPA Filter
  • 42. Working document QAS/15.639/Rev.1 page 40 CHEMICAL DRIER UNIT Reactivation Chemical Drier Air Fan Desiccant Wheel E Fresh Air S = Supply Air R = Return Air F = Fresh Air E = Exhaust Air AIR HANDLING UNIT - F S R + S LOW HUMIDITY PRODUCTION FACILITY R R R 820 821 Figure 13. Air-handling system with chemical drying 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 5.5.2. The figure illustrates the chemical drier handling part of the fresh air/return air mixture on a bypass flow. The location of the chemical drier should be considered in the design phase. The practice of locating the complete chemical drier unit in the production cubicle is not recommended as this could be a source of contamination or cross-contamination. Examples of appropriate locations for the drying wheel could include: — full flow of fresh/return air; — partial handling of fresh/return air (bypass airflow); — return air only; — fresh air only; or — pre-cooled air with any of the above alternatives. 5.5.3. Possible additional components that may be required in air handling should be considered depending on the climatic conditions and locations. These may include items such as: P ri m a ry Filter Process A i r Fan R e a cti va tion H e a te r + P ri m a ry Filter C o o l i n g Coil S u p ply Air Fa n Secondary Fi l te r H E P A Fi l te r 841 ‒ frost coils on fresh air inlets in very cold climates to preheat the air; 842 ‒ reheaters for humidity control; 843 ‒ automatic air volume control devices; 844 ‒ sound attenuators;
  • 43. Working document QAS/15.639/Rev.1 page 41 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 – snow eliminators to prevent snow entering air inlets and blocking airflow; – dust eliminators on air inlets in arid and dusty locations; – moisture eliminators in humid areas with high rainfall; – fresh air precooling coils for very hot or humid climates. – Air-handling units should be provided with adequate drains to remove condensate. 6. PROTECTION 6.1. Products and personnel 6.1.1. Areas for the manufacture of pharmaceuticals, where pharmaceutical starting materials and products, utensils, primary packing materials and equipment are exposed to the environment, should be defined as “clean areas”, “clean zones”, “controlled areas” or “cleanrooms”. 6.1.2. The achievement of a particular clean area condition depends on a number of criteria that should be addressed at the design and qualification stages. A suitable balance between the different criteria will be required in order to create an efficient clean area. 6.1.3. Some of the basic criteria to be considered which affects room cleanliness should include: • building finishes and structure; • dust control and containment; • air filtration; • air change rate or flushing rate; • air flow pattern; • recovery capability; • room pressure; • location of air terminals and directional airflow; • temperature; • relative humidity; • material flow; • personnel flow; • gowning procedures; • equipment movement; • process being carried out (open or closed system); • outside air conditions; • occupancy; • type of product; • cleaning standard operating procedures (SOPs).
  • 44. Working document QAS/15.639/Rev.1 page 42 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 6.1.4. Air filtration and air change rates should be set to ensure that the defined room conditions are attained. 6.1.5. The air change rates should be determined by the manufacturer and designer, taking into account the various critical parameters using a risk- based approach with due consideration of capital and running costs and energy usage. Primarily the air change rate should be set to a level that will achieve the required room condition. 6.1.6. Air change rates are normally determined by the following considerations (could normally vary between 10 and 20 air changes per hour):  area condition required: whether a specific room cleanliness condition is in fact required and whether the room condition is rated for an “at rest” condition or an “operational” condition (air change rate should be selected on need rather than tradition);  the product characteristics (e.g. odours, hygroscopicity, etc.);  the quality and filtration of the supply air;  particulates generated by the manufacturing process;  particulates generated by the operators;  configuration of the room and air supply and extract locations;  sufficient air to achieve containment effect and to flush the area;  sufficient air to cope with the room heat load;  sufficient air to balance extract rates;  sufficient air to maintain the required room pressure. 6.1.7. If a cleanroom classification is specified, the manufacturer should state if the classification is rated for the “as-built” (Figure 14), “at-rest”(Figure 15) or “operational” (Figure 16) conditions. 6.1.8. Room classification tests in the “as-built” condition should be carried out on the bare room, in the absence of any equipment if feasible. Due to equipment size the rooms are constructed around the equipment and therefore the equipment is included in the “as-built” condition. 6.1.9. Room classification tests in the “at-rest” condition should be carried out with the equipment operating where relevant, but without any operators. Because of the amounts of dust usually generated in a solid dosage facility, the clean area classifications would be rated for the “at-rest” condition.
  • 45. Working document QAS/15.639/Rev.1 page 43 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 6.1.10. Room classification tests in the “operational” condition are normally carried out during the normal production process with equipment operating and the normal number of personnel present in the room. When qualifying for the operational condition details of the process operating, number and positions of staff should be stipulated for each room, to enable future qualifications to duplicate the same conditions. 6.1.11. Room recovery tests are performed to determine whether the installation is capable of returning to a specified cleanliness level, temperature, humidity, microbial limits, room pressure, etc. where appropriate, within a finite time. This test is carried out after the above room conditions have reached an OOS state after the HVAC system has been switched off. Room recovery tests should demonstrate a reduction in particle concentration by a factor of 100 within the prescribed time (as per ISO 14644-3 clause B.12) (3). The guidance time period for recovery is about 15 to 20 minutes. In some instances it is not possible to increase the particle concentration by a factor of 100 (such as for an ISO 14644 Class 8 condition) as the high particle concentration can damage the particle counter. In this instance the particle decay method can be used as per ISO 14644-3 clause B.12.3.2. Risk assessments should be carried out to determine which rooms should be subject to recovery tests. Recovery tests are also required to determine how long it takes for specified conditions to be achieved after power failure or system start up. 6.1.12. Materials and products should be protected from contamination and cross-contamination during all stages of manufacture (see also section 6.5 for cross-contamination control). Note: contaminants may result from inappropriate premises (e.g. poor design, layout or finishing), poor cleaning procedures, contaminants brought in by personnel, poor manufacturing process and a poor HVAC system.
  • 46. Working document QAS/15.639/Rev.1 967 968 969 970 971 972 973 974 Figure 14. “As-built” condition Figure 15. “At-rest” condition page 35
  • 47. Working document QAS/15.639/Rev.1 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 page 36 Figure 16. “Operational” condition 6.1.13. Airborne contaminants should be controlled through effective ventilation and filtration. 6.1.14. External contaminants should be removed by effective filtration of the supply air. 6.1.15. Airborne particulates and the degree of filtration should be considered critical parameters with reference to the level of product protection required. 6.1.16. Internal contaminants should be controlled by dilution and flushing of contaminants in the room, or by displacement airflow (see Figures 10, 17 and 21 for examples of methods for the flushing of airborne contaminants). 6.1.17. The level of protection and air cleanliness for different areas should be determined according to the product being manufactured, the process being used and the product’s susceptibility to degradation (Table 3).
  • 48.
  • 49. Working document QAS/15.639/Rev.1 page 37 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 6.2. Air filtration and air patterns Note: The degree to which air is filtered plays an important role in the prevention of contamination and the control of cross-contamination. 6.2.1. The type of filters required for different applications depends on the quality of the ambient air and the return air (where applicable) and also on the air change rates. Table 4 gives the recommended filtration levels for different levels of protection in a pharmaceutical facility. Manufacturers should determine and prove the appropriate use of filters. 6.2.2. Filter classes should always be linked to the standard test method because referring to actual filter efficiencies can be very misleading (as different test methods each result in a different efficiency value for the same filter). (Referring to filter classifications such as an 85% filter or a 5 μm filter are not valid classifications and should not be used, as this can lead to the incorrect filter being installed. Only the EN 779 and EN 1822 or ISO 29463 classifications, or ASHRAE Merv classifications, as per Tables 1 and 2, should be used.)
  • 50. Working document QAS/15.639/Rev.1 page 38 1022 1023 1024 1025 1026 Table 2. Comparison of filter test standards Eurovent 4/5 rating ASHRAE 52.2 Eurovent 4/5 ASHRAE 52.1 BS6540 Part 1 Eurovent 4/5 ASHRAE 52.1 BS6540 Part 1 EN 779 & EN 1822 ISO 29463 (superseded) Merv rating Average arrestance Am (%) Average dust spot efficiency Em (%) MPPS integral overall efficiency (%) EN rating 99.999995 U17 EN 1822: 2009 75E 99.99995 U16 65E EU 14 99.9995 U15 55E EU 13 Merv 18 99.995 H14 45E EU 12 Merv 17 99.95 H13 35E EU 11 99.5 E12 25E EU 10 95 E11 15E EU 9 Merv 16 >95 85 E10 EU 9 Merv 15 95 F9 EN 779: 2012 EU 8 Merv 14 90 MPPS = most penetrating particle size F8 Merv 13 >98 85 F7 EU 7 >98 80 Merv 12 >95 75 EU 6 >95 70 M6 Merv 11 >95 65 >95 60 Merv 10 >95 55 EU 5 Merv 9 >95 50 M5 Merv 8 >95 45 >95 40 Merv 7 >90 35 EU 4 >90 30 G4 Merv 6 90 25 EU 3 Merv 5 85 20 G3 80 <20 Merv 4 75 EU 2 Merv 3 70 G2 Merv 2 65 EU 1 Merv 1 <65 G1 Note: The filter classifications referred to above relate to the EN 1822:2009 and EN 779: 2012 test standards (EN 779 relates to filter
  • 51. Working document QAS/15.639/Rev.1 page 39 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 104 59 0 classes G1 to F9 and EN 1822 relates to filter classes E10 to U17). Most penetrating particle size (MPPS) is a means of determining HEPA and ultra low penetration air (ULPA filter efficiencies). The MPPS is the particle size with the highest penetration for a defined filter medium. (MPPS integral overall efficiency is the efficiency, averaged over the whole superficial face area of a filter element under a given operating conditions of the filter. MPPS local efficiency is the efficiency, at a specific point of the filter element under given operating conditions of the filter). Note: ULPA filters are not applicable to pharmaceutical installations. 6.2.3. In selecting filters, the manufacturer should have considered other factors, such as particularly contaminated ambient conditions, local regulations and specific product requirements. Good prefiltration extends the life of the more expensive filters downstream. 6.2.4. Filters have an impact on the cleanroom class or level of protection. The different levels of protection and recommended filters grades are given in Tables 3 and 4 below. Table 3. Examples of levels of protection (based on ISPE oral solid dosage (OSD) guideline criteria) Level Condition Example of area Level 1 General Area with normal housekeeping and maintenance where there is no potential for product contamination, e.g. warehousing. Level 2 Protected Area in which steps are taken to protect the pharmaceutical starting material or product from direct or indirect contamination or degradation, e.g. secondary packing, warehousing, first stage change rooms.
  • 52. Working document QAS/15.639/Rev.1 page 40 Level 3 Controlled Area in which specific environmental conditions are defined, controlled and monitored to prevent contamination or degradation of the pharmaceutical starting material or product, e.g. where product, starting materials and components are exposed to the room environment; plus equipment wash and storage areas for equipment product contact parts. 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 Table 4. Levels of protection and recommended filtration Level of protection Recommended filtration Level 1 Primary filters only (e.g. EN 779 G4 filters) Level 2 Protected areas operating on recirculated or full fresh air Primary plus secondary filters (e.g. EN 779 G4 plus F8 or F9 filters) Level 3 Production facility operating on recirculated plus ambient air, where potential for cross- contamination exists: Primary plus secondary plus tertiary filters (e.g. EN 779 G4 plus F8 plus EN 1822 H13 filters) (for full fresh air system, without recirculation, G4 and F8 or F9 filters are acceptable) 6.2.5. Directional airflow within production or primary packing areas should assist in preventing contamination. Airflows should be planned in conjunction with operator locations, so as to minimize contamination of the product bythe operator and also to protect the operator from dust inhalation. An example of flushing effect with turbulent airflow and low level extract is indicated in Figure 17 below. 6.2.6. At airlocks and change rooms supply air and extract air terminals should be positioned such that air flows from the clean side of the room to the less clean side, to enhance the separation between the two adjoining rooms.
  • 53. Working document QAS/15.639/Rev.1 page 41 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 Figure 17. Turbulent dilution of dirty air Low-level extract is ideal for dust suppression purposes, but is not essential where no dust is liberated. (Low-level extract is essential for Grade C classified areas – for information only.) 6.2.7. Supply air diffusers should beselected with care taking consideration of, e.g. room requirements and positions of equipment and operators in the room. Supply air diffusers of the high induction type (e.g. those typically used for office-type air-conditioning) should where possible not be used in clean areas where dust is liberated. Air diffusers should be of the non- induction type, introducing air with the least amount of induction so as to maximize the flushing effect. In rooms where the process results in high dust liberation; perforated plates or low induction swirl diffusers with low level extract or return should be used (to contain the dust at the lower level of the room) (see Figures 18–20 for illustrations of the three types of diffuser). Although ceiling returns are generally avoided in cases where dust liberation is low, ceiling return air grilles may be acceptable.
  • 54. Working document QAS/15.639/Rev.1 page 42 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 6.2.8. The type of diffusers used for each room should be carefully selected considering their air flow patterns and the amount of dust liberated in the room. Induction and certain swirl diffusers create good dilution of room air and may be used where dust liberation is minimal. If used in rooms where significant dust is generated, their use may draw dust up into the air stream and spread it throughout the room, presenting increased hazards to containment and to operators. Some swirl type diffusers have less induction (as indicated in Figure 20) 6.2.9. Airflow patterns for different diffuser types are indicated in Figures 18, 19 and 20 below. Figure 18. Induction diffuser
  • 55. Working document QAS/15.639/Rev.1 page 43 1108 1109 1110 1111 1112 1113 Figure 19. Perforated plate diffuser Figure 20. Swirl diffuser
  • 56. Working document QAS/15.639/Rev.1 page 44 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 6.3. Unidirectional airflow 6.3.1. Unidirectional airflow (UDAF) should be used for weighing booths or sampling booths to provide operator and product protection and should also have a slight air in-flow from the room to enhance containment. Dust containment at the weigh booth should be demonstrated by smoke airflow pattern tests (AFPT), or other appropriate tests. UDAF can also be used to provide protection of other dusty processes. 6.3.2. Sampling of materials such as starting materials, primary packaging materials and products, should be carried out in the same environmental conditions that are required for the further processing of the product. 6.3.3. In a weighing booth situation, the aim of the UDAF is to provide dust containment and operator protection. The weigh booth and dispensary should have the same environmental conditions that are required for the further processing of the product. Example: in Figure 21 the dust generated at the weighing station is immediately extracted through the perforated worktop, thus protecting the operator from dust inhalation, but at the same time protecting the product from contamination by the operator by means of the vertical unidirectional airflow stream. Figure 21. Operator protection at weighing station
  • 57. Working document QAS/15.639/Rev.1 page 45 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 6.3.4 The unidirectional flow velocity should be such that it does not disrupt the sensitivity of balances in weighing areas. However, the airflow velocity and directional flow should be appropriate to ensure product containment and operator protection. For this type of application it is sometimes better to refer to the unit as an airflow protection booth (APB) rather than a UDAF, in order to avoid confusion, with a Grade A requirement. To assist with containment for weighing and sampling operations there should be a slight inflow of air into the UDAF protected zone from the surrounding room in order to prevent dust escaping. Thus the amount of air extracted from below the UDAF/APB should exceed the amount of air supplied. 6.3.5 The position in which the operator stands relative to the source of dust liberation and airflow should be determined to ensure that the operator is not in the path of an airflow that could lead to contamination of the product (Figure 22). Figure 22. Operator protection by horizontal airflow
  • 58. Working document QAS/15.639/Rev.1 page 46 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 6.3.6 Once the system has been designed and qualified with a specific layout for operators and processes, this configuration should be maintained in accordance with an SOP. 6.3.7 There should be no obstructions in the path of a unidirectional flow air stream that may cause the operator to be exposed to dust. Figure 23 illustrates the incorrect use of a weighing scale which has a solid back. The back of the weighing scale should not block the return air path as this obstructs the airflow and causes air to rise vertically carrying dust, resulting in a hazardous situation for the operator. Figure 24 illustrates a situation where an open bin is placed below a vertical unidirectional airflow distributor. The downward airflow should be prevented from entering the bin, and then being forced to rise again, as this
  • 59. Working document QAS/15.639/Rev.1 page 47 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 would carry light dust up towards the operator’s face. In such an occurrence it may be necessary to add a partial cover over the bin to limit the entry of air. Point extraction could also be used but this can result in the excessive loss of product. Figure 25 shows that a solid worktop can sometimes cause deflection of the vertical unidirectional airflow resulting in a flow reversal. A possible solution would be to have a 100 mm gap between the back of the table and the wall, with the air being extracted here, or have a perforated worktop with extraction below..
  • 60. Working document QAS/15.639/Rev.1 page 48 1188 1189 1190 1191 1192 1193 Figure 23. Operator subject to powder inhalation due to obstruction Figure 24. Operator subject to powder contamination due to airflow reversal in bin
  • 61. Working document QAS/15.639/Rev.1 page 49 1194 1195 1196 1197 1198 1199 1200 1201 Figure 25. Operator subject to powder inhalation due to worktop obstruction 6.3.8 The manufacturer should select either vertical or horizontal unidirectional airflow (Figure 26), and an appropriate airflow pattern to
  • 62. Working document QAS/15.639/Rev.1 page 50 1202 1203 1204 1205 1206 1207 1208 provide the best protection for the particular application. Figure 26. Diagram indicating horizontal and vertical unidirectional flow
  • 63. Working document QAS/15.639/Rev.1 page 51 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 6.3.9 Return or exhaust air grilles in rooms or at weigh or sampling booths should preferably be of the perforated grille types, which are easy to clean. Return/exhaust air filters can either be installed at the room terminal or in the air-handling unit. Maintenance and cleaning of filters and ducts should be addressed to ensure constant airflow. 6.4. Infiltration 6.4.1. Air infiltration of unfiltered air into a pharmaceutical plant should not be a source of contamination. 6.4.2. Manufacturing facilities should normally be maintained at a positive pressure relative to the outside, to limit the ingress of contaminants. Where facilities are to be maintained at negative pressures relative to the ambient pressure, special precautions should be taken. Refer to the WHO guidelines for hazardous products, for further guidance on negative pressure facilities. 6.4.3. The location of the negative pressure facility should be carefully considered with reference to the areas surrounding it, particular attention being given to ensuring that the building structure is well sealed. 6.4.4. Negative pressure zones should, as far as possible, be encapsulated by surrounding areas with clean air supplies, so that only clean air can infiltrate into the controlled zone. 6.5. Cross-contamination and contamination 6.5.1. Where different products are manufactured at the same time, in different areas or cubicles, in a multiproduct OSD manufacturing site, measures should be taken to ensure that dust cannot move from one cubicle to another. 6.5.2. Correct directional air movement and a pressure cascade system can assist in preventing cross-contamination. The pressure cascade should be such that the direction of airflow is from the clean corridor into the cubicles, resulting in dust containment. 6.5.3. For cubicles where dust is liberated, the corridor should be maintained at a higher pressure than the cubicles and the cubicles at a higher pressure than atmospheric pressure. (For negative pressure facilities
  • 64. Working document QAS/15.639/Rev.1 page 52 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 refer to WHO Technical Report Series, No. 957, Annex 3 for hazardous products guidelines and design conditions.) 6.5.4. Containment can normally be achieved by application of the pressure differential concept (high pressure differential, low airflow), or the displacement concept (low pressure differential, high airflow), or the physical barrier concept, as described in ISO 14644-4. However, the “low pressure differential, high airflow” method is no longer used as a means of room segregation. 6.5.5. The pressure cascade for each facility should be individually assessed according to the product handled and level of protection required. The pressure cascade regime and the direction of airflow should be appropriate to the product and processing method used, and should also provide operator and environmental protection. 6.5.6. Building structure should be given special attention to accommodate the pressure cascade design. 6.5.7. Ceilings and walls, close fitting doors and sealed light fittings should be in place, to limit ingress or egress of air. 6.6. Pressure differential concept (high pressure differential, low airflow) Note: The pressure differential concept may be used alone or in combination with other containment control techniques and concepts, such as a double door airlock. 6.6.1. The high pressure differential between the clean and less clean zones should be generated by balancing the supply and extract air quantities in the two adjoining rooms, thus resulting in the pressure gradient. Leakage through the cracks around the door, as a result of the pressure differential, is acceptable. 6.6.2. The pressure differential should be of sufficient magnitude to ensure containment and prevention of flow reversal, but should not be so high as to create turbulence problems. 6.6.3. In considering room pressure differentials, transient variations, such as machine extract systems, should be taken into consideration. 6.6.4. A pressure differential of 15 Pa is often used for achieving containment between two adjacent zones, but pressure differentials of
  • 65. Working document QAS/15.639/Rev.1 page 53 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 between 5 Pa and 20 Pa may be acceptable. Where the design pressure differential is too low and tolerances are at opposite extremities, a flow reversal can take place. For example, where a control tolerance of ± 3 Pa is specified, the implications of adjacent rooms being operated at the upper and lower tolerances should be evaluated. It is important to select pressures and tolerances such that a flow reversal is unlikely to occur. 6.6.5. The pressure differential between adjacent rooms could be considered a critical parameter, depending on the outcome of risk analysis. The limits for the pressure differential between adjacent areas should be such that there is no risk of overlap in the acceptable operating range, e.g. 5 Pa to 15 Pa in one room and 15 Pa to 30 Pa in an adjacent room, resulting in the failure of the pressure cascade, where the first room is at the maximum pressure limit and the second room is at its minimum pressure limit. 6.6.6. Low pressure differentials may be acceptable when airlocks (pressure sinks or pressure bubbles) are used to segregate areas. 6.6.7. The effect of room pressure tolerances are illustrated in Figure 27. If one room is at the higher side of the tolerance and the other at the lower side of the tolerance, it could result in either a high or a low pressure differential. When setting tolerances it is also important to specify if the tolerance is applicable to the absolute room pressures or the pressure differentials. In the diagram below the tolerances have been based on a ± 3 Pa tolerance on absolute room pressures, resulting in pressure differential variances of between 21 and 9 Pa. For a room pressure differential of 15 Pa and a tolerance based on ± 3 Pa of differential pressure, then the resultant variances would only be between 12 and 18 Pa.
  • 66. Working document QAS/15.639/Rev.1 page 54 15 Pa ± 3 Pa Air Leak akage Encapsulation 15 Pa ± 3 Pa Compression Compression 15 Pa ± 3 Pa 15 Pa ± 3 Pa Production Corridor 30 Pa ± 3 Pa Air Le age Tablet Tablet Airlock 1326 Figure 27. Examples of pressure cascades Design Condition (15 Pa Pressure Differential) 1327 1328 Maximum Differential (21 Pa Pressure Differential) Minimum Differential (9 Pa Pressure Differential) 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 6.6.8. The pressure control and monitoring devices used should be calibrated and qualified. Compliance with specifications should be regularly verified and the results recorded. Pressure control devices should be linked to an alarm system set according to the levels determined by a risk analysis. 6.6.9. Manual control systems, where used, should be set up during commissioning, with set point marked, and should not change unless other system conditions change. 6.6.10. Airlocks can beimportant components in setting up and maintaining pressure cascade systems and also to limit cross-contamination. 6.6.11. Airlocks with different pressure cascade regimes include the cascade airlock, sink airlock and bubble airlock (Figures 28–30):  cascade airlock: higher pressure on one side of the airlock and lower pressure on the other;  sink airlock: lower pressure inside the airlock and higher pressure on both outer sides;  bubble airlock: higher pressure inside the airlock and lower pressure on both outer sides. e age 12 Pa Air Leak akage Airlock Air L Production Corridor 33 Pa Encapsulation 12 Pa Tablet Compression 12 Pa Tablet Compression 12 Pa Airlock akage Air Leak 18 Pa Air L Production Corridor 27 Pa Encapsulation 18 Pa Tablet Compression 18 Pa Tablet Compression 18 Pa e age Image ofroompressure gauge indicating colour coded norm al, alert & action parameters Air Leakage Air Leakage Air Leakage Air Leakage Air Leakage Air Leakage Air Leakage Air Leakage Air Leakage
  • 67. Working document QAS/15.639/Rev.1 page 55 1352 1353 1354 1355 1356 Figure 28. Example of cascade airlock (In most cases the internal pressure of the airlock is not critical. The pressure differential between the two outer sides is the important criteria.) 1357 1358 Air Leakage Air Leakage 15 Pa Material Airlock 22.5 Pa 30 Pa CascadeAirlock
  • 68. Working document QAS/15.639/Rev.1 page 56 1359 1360 Figure 29. Example of sink airlock 1361 1362 Air Leakage Air Leakage 30 Pa Material Airlock 30 Pa 15 Pa Sink Airlock
  • 69. Working document QAS/15.639/Rev.1 page 57 1363 1364 Figure 30. Example of bubble airlock 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 Note: The diagrams above and the differential pressures shown here are for illustration purposes only. Pressures indicated in these examples are absolute pressures, whereas the local pressure indication would most likely be pressure differential from room to room. 6.6.12. Doors should open to the high pressure side, so that room pressure assists in holding the door closed and in addition be provided with self- closers. Should the doors open to the low pressure side, the door closer springs should be sufficient to hold the door closed and prevent the pressure differential from pushing the door open. There should be a method to indicate if both doors to airlocks are open at the same time, or alternatively these should be interlocked such that only one door can be opened at a time. The determination of which doors should be interlocked should be the subject of a risk assessment study. 6.6.13. Risk assessment should be done to determine whether dust extraction systems should be interlocked to the appropriate air-handling systems. Failure to interlock fans could result in pressure cascade imbalances. Air Leakage Air Leakage 15 Pa Material Airlock 30 Pa 15 Pa Bubble Airlock
  • 70. Working document QAS/15.639/Rev.1 page 58 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 6.6.14. Air should not flow through the dust extraction ducting or return air ducting from the room with the higher pressure to the room with the lower pressure (this would normally occur only if extract or return systems were inoperative). Systems should be designed to prevent dust flowing back in the opposite direction in the event of component failure or airflow failure. 6.6.15. Adequate room pressure differential indication should be provided so that each critical room pressure can be traced back to ambient pressure (by summation of the room pressure differentials), in order to determine the room actual absolute pressure. A pressure gauge installed to indicate the pressure differential from a central corridor to ambient could serve to trace pressures to ambient. 6.6.16. Room pressure indication gauges should have a range and graduation scale which enables the reading to an appropriate accuracy. Normal operating range, alert and action limits should be defined and displayed at the point of indication. A colour coding of these limits on the gauge may behelpful. Room pressure indication may be either analogue or digital, and may be represented as either pressure differentials or absolute pressures. Whichever system is used any out-of-specification (OOS) condition should be easily identifiable. Zero setting of gauges should be frequently checked (such as, weekly) and zero setting should preferably be tamper proof. 6.6.17. Material PTHs or pass boxes (PB) can also be used for separating two different zones. PTHs fall into two categories, namely a dynamic PTH or a passive PTH. Dynamic PTHs have an air supply to or extraction from them, and can then be used as bubble, sink or cascade PTHs. 6.6.18. Room pressure differential tolerances should always be set with a maximum and minimum tolerance. Setting tolerances as NMT or NLT can easily lead to an OOS condition. 6.7. Physical barrier concept 6.7.1. Where appropriate, an impervious barrier to prevent cross- contamination between two zones, such as closed manufacturing and transfer systems, pumped or vacuum transfer of materials, should be used.
  • 71. Working document QAS/15.639/Rev.1 page 59 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 6.8. Temperature and relative humidity 6.8.1. Where appropriate, temperature and relative humidity should be controlled, monitored and recorded, where relevant, to ensure compliance with requirements pertinent to the materials and products and provide a comfortable environment for the operator where necessary. 6.8.2. Maximum and minimum room temperatures and relative humidity should be appropriate. Alert and action limits on temperatures and humidities should be set, as appropriate. 6.8.3. The operating band, or tolerance, between the acceptable minimum and maximum temperatures should not be made too close. Tight control tolerances may be difficult to achieve and can also add unnecessary installation and running costs. 6.8.4. Cubicles, or suites, in which products requiring low relative humidity are processed, should have well-sealed walls and ceilings and should also be separated from adjacent areas with higher relative humidity by means of suitable airlocks. 6.8.5. Precautions should be taken to prevent moisture migration that increases the load on the HVAC system. 6.8.6. Humidity control should be achieved by removing moisture from the air, or adding moisture to the air, as relevant. 6.8.7. Dehumidification (moisture removal) may be achieved by means of either refrigerated dehumidifiers (cooling coils) or chemical dehumidifiers. 6.8.8. Humidifiers should be avoided if possible as they may become a source of contamination (e.g. microbiological growth). Where humidification is required, this should be achieved by appropriate means such as the injection of steam into the air stream. A product-contamination assessment should be done to determine whether purified water or clean steam is required for the purposes of humidification. 6.8.9. Humidification systems should be well drained. No condensate should accumulate in air-handling systems. 6.8.10. Other humidification appliances such as evaporative systems, atomizers and water mist sprays, should not be used because of the potential risk of microbial contamination. 6.8.11. Duct material in the vicinity of the humidifier should not add contaminants to air that will not be removed byfiltration further downstream.
  • 72. Working document QAS/15.639/Rev.1 page 60 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 6.8.12. Air filters should not be installed immediately downstream of humidifiers, as moisture on the filters could lead to bacterial growth. 6.8.13. Cold surfaces should be insulated to prevent condensation within the clean area or on air-handling components. 6.8.14. When specifying relative humidity, the associated temperature should also be specified. 6.8.15. Chemical driers using silica gel or lithium chloride are acceptable, provided that they do not become sources of contamination. 7. DUST CONTROL 7.1. Wherever possible, dust or vapour contamination should be removed at source. Point-of-use extraction, i.e. as close as possible to the point where the dust is generated, should be employed. Spot ventilation or capture hoods may be used as appropriate. The HVAC system should not serve as the primary mechanism of dust control. 7.2. Point-of-use extraction should be either in the form of a fixed, high-velocity extraction point or an articulated arm with movable hood or a fixed extraction hood. Care should be taken in the design and positioning of dust extract points to prevent cross-contamination by powders dropping down from the extract point. 7.3. Dust extraction ducting should be designed with sufficient transfer velocity to ensure that dust is carried away, and does not settle in the ducting. Periodic checks should be performed to ensure that there is no build-up of the dust in the ducting. 7.4. The required transfer velocity should be determined: it is dependent on the density of the dust (the denser the dust, the higher the transfer velocity should be, e.g. 15–20 m/s). 7.5. Airflow direction should be carefully chosen, to ensure that the operator does not contaminate the product, and also so that the operator is not put at risk by the product. 7.6. Point extraction alone is usually not sufficient to capture all of the contaminants, and general directional airflow should be used to assist in removing dust and vapours from the room. 7.7. Typically, in a room operating with turbulent airflow, the air should be introduced from ceiling diffusers, located at the door entry side of the room and extracted from the rear of the room at low level to help give a
  • 73. Working document QAS/15.639/Rev.1 page 61 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 flushing effect in the room. Correct flushing of the rooms may be verified by airflow visualization smoke tests. 7.8. When dealing with particularly harmful products, additional steps, such as handling the products in glove boxes or using barrier isolator technology, should be used (refer to WHO Technical Report Series, No. 957, Annex 3 for additional guidance on handling hazardous products). 8. PROTECTION OF THE ENVIRONMENT 8.1. General 8.1.1. It should benoted that protection of the environment is not addressed in this guideline, and discharges into the atmosphere should be compliant with relevant local and national environmental legislation and standards. 8.1.2. Dust, vapours and fumes could be possible sources of contamination; therefore, care should be taken when deciding on the location of the inlet and exhaust points relative to one other. 8.2. Dust in exhaust air 8.2.1. Exhaust air discharge points on pharmaceutical equipment and facilities, such as from fluid bed driers and tablet-coating equipment, and exhaust air from dust extraction systems, carry heavy dust loads and should be provided with adequate filtration to prevent contamination of the ambient air. 8.2.2. Where the powders are not highly potent, final filters on a dust exhaust system should be fine dust filters with a filter classification of F9 according to EN 779 filter standards. 8.2.3. Where reverse-pulse dust collectors are used for removing dust from dust extraction systems, they should usually be equipped with cartridge filters containing a compressed air lance, and be capable of continuous operation without interrupting the airflow. 8.2.4. Alternative types of dust collectors (such as those operating with a mechanical shaker, requiring that the fan be switched off when the mechanical shaker is activated) should be used in such a manner that there is no risk of cross-contamination. There should be no disruption of airflow during a production run as the loss of airflow could disrupt the pressure cascade. 8.2.5. Mechanical-shaker dust collectors should not beused for applications where continuous airflow is required, in order to avoid unacceptable
  • 74. Working document QAS/15.639/Rev.1 page 62 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 fluctuations in room pressures, except in the case where room pressures are automatically controlled. 8.2.6. When wet scrubbers are used, the dust-slurry should be removed by a suitable means, e.g. a drainage system or waste removal contractor. 8.2.7. The quality of the exhaust air should be determined to see whether the filtration efficiency is adequate with all types of dust collectors and wet scrubbers. 8.2.8. Where necessary, additional filtration may be provided downstream of the dust collector. 8.3. Vapour and fume removal 8.3.1. Vapour should be extracted at the point of generation. When planning the system for the extraction of residual vapours, the density of the vapour should be taken into account. If the vapour is lighter than air, the extract grilles should be at a high level, or possibly at both high and low levels. 8.3.2. The systems for fume, dust and effluent control should be designed, installed and operated in such a manner that they do not become possible sources of contamination or cross-contamination, e.g. an exhaust-air discharge point located close to the HVAC system fresh air inlet. 8.3.3. Fumes should be removed by means of wet scrubbers or dry chemical scrubbers (deep-bed scrubbers). 8.3.4. Wet scrubbers for fume removal normally require the addition of various chemicals to the water to increase the adsorption efficiency. 8.3.5. Deep-bed scrubbers should be designed with activated carbon filters or granular chemical adsorption media. The chemical media for deep-bed scrubbers should be specific to the effluent being treated. 8.3.6. The type and quantity of the vapours to be removed should be known to enable the appropriate filter media, as well as the volume of media required to be determined. 9. COMMISSIONING, QUALIFICATION AND VALIDATION 9.1. General 9.1.1. The HVAC system plays an important role in the protection of the product, the personnel and the environment.
  • 75. Working document QAS/15.639/Rev.1 page 63 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 9.1.2. For all HVAC installation components, subsystems or parameters, critical parameters and non-critical parameters should be determined. 9.2. Commissioning 9.2.1. Commissioning should involve the setting up, balancing, adjustment and testing of the entire HVAC system, to ensure that the system meets all the requirements, as specified in the user requirement specification, and capacities as specified by the designer or developer. The commissioning plan should start at the early stages of a project so that it can be integrated with qualification and verification procedures. 9.2.2. Acceptable tolerances for all system parameters should be specified and agreed by the user prior to commencing the physical installation. These tolerances should be specified in the user requirement specifications 9.2.3. Acceptance criteria should be set for all system parameters. The measured data should fall within the acceptance criteria. 9.2.4. System installation records should provide documented evidence of all measured capacities of the system. 9.2.5. The i n s t al l at i o n r e co r ds should include items such as the design and measured figures for airflows, water flows, system pressures electrical amperages, etc. These should be contained in the operating and maintenance manuals (O & M manuals). The installation records of the system should provide documented evidence of all measured capacities of the system. 9.2.6. Typical information that should be contained in the O&M manuals is the following:  system description;  operating instructions;  trouble shooting;  commissioning data schedules;  maintenance instructions;  list of equipment suppliers;  spare parts lists;  equipment capacity and data schedules;  supplier’s literature;
  • 76. Working document QAS/15.639/Rev.1 page 64 System 2 System 1 Process A number of Qualified systems make up a Validated process. 1657  control system operation; 1658  electrical drawings; 1659  as-built drawings; 1660  maintenance records. 1661 1662 9.2.7. O & M manuals, schematic drawings, protocols and reports should 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 be maintained as reference documents for any future changes and upgrades to the system. As-built drawings should be available and should be kept up to date with all the latest system changes. Any changes from the originally approved system should be covered by change control documentation and risk assessment studies where deemed necessary. 9.2.8. Training should be provided to personnel after installation of the system, and should include how to perform operation and maintenance. 9.2.9. Commissioning should be a precursor to system qualification and validation. 9.3. Qualification 9.3.1. Manufacturers should qualify HVAC systems using a risk-based approach. The basic concepts of qualification of HVAC systems are set out in Figure 31 below. Figure 31. Qualification is a part of validation Equipment Equipment Equipment Equipment Equipment Equipment Equipment 1 2 3 4 5 6 7 9.3.2. The qualification of the HVAC system should be described in a validation master plan (VMP), or a subsection of the VMP. Qualification Validation
  • 77. Working document QAS/15.639/Rev.1 page 65 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 9.3.3. The VMP should define the nature and extent of testing and the test procedures and protocols to be followed. 9.3.4. Stages of the qualification of the HVAC system should include design qualification (DQ), installation qualification (IQ), operational qualification (OQ) and performance qualification (PQ). The relationship between the development stage of a project (user requirement specification, functional design specification, detail design and configuration specifications, build & project implementation) and the qualification stages are given in the V-diagram (Figure 32) below. The V- model is one example of an approach to qualification and validation. Figure 32. V-Model for Direct Impact Systems User Requirement Specification Functional Design Specification Detail Design and Configuration Specifications PQ Test Plan (incl. UAT) OQ Test Plan (incl. SAT) IQ Test Plan (incl. FAT/PDI) Performance Qualification Operational Qualification Installation Qualification Build & Project Implementation 1699 1700 1701 1702 1703 1704 1705 SAT, FAT & PDI where applicable, could take place at different stages depending on the application UAT=user acceptance tests; FAT=factory acceptance tests; SAT=site acceptance tests; PDI=pre-delivery inspections. 9.3.5. Critical and non-critical parameters for all HVAC installation components, subsystems and controls should be determined by means of a risk analysis. DQ Test Plan Design Qualification